ID,Citing Source Item,Cited Source Item Number,DocumentID,Type,ID,DOI,WOS,PMID,Note,Reference,
206,PresComReport,1,373,Article,,,WOS:A1980JA35200026,7350425,,"Porter J, Jick H. 1980, Jan 10. Addiction rare in patients treated with narcotics. N Engl J Med. 302(2):123.",
207,PresComReport,2,325,Article,,,WOS:000402390400016,28564561,,"Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN. 2017, Jun 1. A 1980 Letter on the Risk of Opioid Addiction. N Engl J Med. 376(22):2194-2195.",
208,PresComReport,3,240,Article,,,,2873550,,"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Portenoy RK, Foley KM. Pain. 1986 May;25(2):171-86. PMID: 2873550 https://www.ncbi.nlm.nih.gov/pubmed/2873550",
209,PresComReport,4,350,Article,,,WOS:A1990CJ02500001,2296714,,Melzack R. 1990. The tragedy of needless pain. Sci Am. 262(2):27-33.,
210,PresComReport,5,372,Article,,,,1969892,,"Portenoy RK. 1990, Feb. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage (1 Suppl):S46-62.",
211,PresComReport,6,343,Article,,,WOS:A1990EK55800012,2240903,,Max MB. Improving outcomes of analgesic treatment: is education enough? Ann Intern Med. 1990;113(11):885- 889.,
212,PresComReport,7,343,Article,,,WOS:A1990EK55800012,2240903,,Max MB. Improving outcomes of analgesic treatment: is education enough? Ann Intern Med. 1990;113(11):885- 889.,
213,PresComReport,8,375,Report,GAO-04-110,,,,,PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem. Available at https://www.gpo.gov/fdsys/pkg/GAOREPORTS-GAO-04-110/pdf/GAOREPORTS-GAO-04-110.pdf,
214,PresComReport,9,218,Article,,,WOS:A19637859A00001,13971810,,Bloomquist ER. 1963 Aug. The addiction potential of oxycodone (Percodan). Calif Med. 99:127-30.,
215,PresComReport,10,408,Article,,10.2105/AJPH.2007.131714,WOS:000262795100007,18799767,,"Van Zee A. 2009. The promoion and marketing of OxyContin: commercial triumph, public health tragedy. Am. J. Public Health 99:221–27.",
216,PresComReport,11,389,Article,,10.1146/annurev-pharmtox-010617-052534,,28968188,,Skolnick P. The Opioid Epidemic: Crisis and Solutions. Annu Rev Pharmacol Toxicol. 2017 Oct 2. [Epub ahead of print],
217,PresComReport,12,258,Article,,,WOS:000348119200008,25587948,,"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, et al. 2015. Trends in opioid analgesic abuse and mortality in the United States. N. Engl. J. Med. 372:241–48",
218,PresComReport,13,247,Article,,,WOS:000339165200013,24871348,,"Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. 2014. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 71:821–26.",
219,PresComReport,14,405,Website,,,,,,The United States Senate Committee on Finance Website. http://www.finance.senate.gov/chairmans-news/baucusgrassley-seek-diagnosiss-about-opioid-manufacturers-ties-to-medical-groups.,
220,PresComReport,15,326,Article,,,WOS:000396201000030,28114444,,"Lin DH, Lucas E, Murimi IB, Kolodny A, Alexander GC. 2017 Mar 1. Financial Conflicts of Interest and the Centers for Disease Control and Prevention's 2016 Guideline for Prescribing Opioids for Chronic Pain. JAMA Intern Med. 177(3):427-428.",
221,PresComReport,16,248,Article,,,WOS:000208687500007,22287798,,"Cicero TJ, Kurtz SP, Surratt HL, Ibanez GE, Ellis MS, Levi-Minzi MA, Inciardi JA. 2011 spring. Multiple Determinants of Specific Modes of Prescription Opioid Diversion. J Drug Issues. 41(2):283-304.",
222,PresComReport,17,226,Article,,,WOS:A1996UB56000016,,,Campbell JN. APS 1995 Presidential address. Pain Forum. 1996;5:85–8.,
223,PresComReport,18,410,Report,,,,,,Veterans Health Administration. Pain as the 5th Vital Sign Toolkit. 2000. https://www.va.gov/PAINMANAGEMENT/docs/Pain_As_the_5th_Vital_Sign_Toolkit.pdf.,
224,PresComReport,19,370,Article,,,WOS:000088254200005,10904487,,"Phillips DM. 2000, Jul 26. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA. 284(4):428-9.",
225,PresComReport,20,211,Article,,,WOS:000396987200013,28241189,,"Baker DW. 2017, Mar 21. History of The Joint Commission's Pain Standards: Lessons for Today's Prescription Opioid Epidemic. JAMA. 317(11):1117-1118.",
226,PresComReport,21,211,Article,,,WOS:000396987200013,28241189,,"Baker DW. 2017, Mar 21. History of The Joint Commission's Pain Standards: Lessons for Today's Prescription Opioid Epidemic. JAMA. 317(11):1117-1118.",
227,PresComReport,22,236,Article,,,WOS:000404717700023,28672310,,"Chhabra N, Leikin JB. 2017, Jul 4. The Joint Commission and the Opioid Epidemic. JAMA. 318(1):91-92.",
228,PresComReport,23,210,Article,,,WOS:000404717700024,28672313,,"Baker DW. 2017, Jul 4. The Joint Commission and the Opioid Epidemic-Reply. JAMA. 318(1):92.",
229,PresComReport,24,306,Report,,,,,,https://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/1998_grpol_Pain_Management_Guidelines.pdf,
230,PresComReport,25,403,Report,,,,,,The Joint Commission. Pain management. https://www.jointcommission.org/topics/pain_management.aspx. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL,
231,PresComReport,26,408,Article,,10.2105/AJPH.2007.131714,WOS:000262795100007,18799767,,"Van Zee A. 2009. The promotion and marketing of OxyContin: commercial triumph, public health tragedy. Am J Public Health. 99(2):221-227.",
232,PresComReport,27,367,Report,,,,,,"Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use, The National Academies Press. http://nationalacademies.org/hmd/Reports/2017/pain-managementand-the-opioid-epidemic.aspx",
233,PresComReport,28,396,Report,,,,,,"Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse. 2017, July 13. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm566958.htm",
234,PresComReport,29,301,Report,,,,,,https://www.cdc.gov/drugoverdose/data/prescribing.html,
235,PresComReport,30,262,Article,,,WOS:000324751000004,24025657,,"Daubresse M, Chang H, Yu Y, Viswanathan S, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000 – 2010. Medical Care 2013; 51(10): 870- 878. http://dx.doi.org/10.1097/MLR.0b013e3182a95d86",
236,PresComReport,31,334,Article,,,WOS:000400464300006,28355456,,"Madras BK. 2017, May 1. The Surge of Opioid Use, Addiction, and Overdoses: Responsibility and Response of the US Health Care System. JAMA Psychiatry. 74(5):441-442.",
237,PresComReport,32,238,Article,,,,28705485,,"Chiu AS, Healy JM, DeWane MP, Longo WE, Yoo PS. 2017, Jul 10. Trainees as Agents of Change in the Opioid Epidemic: Optimizing the Opioid Prescription Practices of Surgical Residents. J Surg Educ. pii: S1931- 7204(17)30157-5.",
238,PresComReport,33,333,Article,,,WOS:000277795700019,20201863,,"Madras BK. 2010 Feb. Office of National Drug Control Policy: a scientist in drug policy in Washington, DC. Ann N Y Acad Sci. 1187:370-402.",
239,PresComReport,34,332,Article,,,WOS:000262700500031,18929451,,"Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. 2009, Jan 1. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 99(1-3):280-95.",
240,PresComReport,35,283,Article,,,WOS:000346033600016,25247895,,"Gupta A, Lee LK, Mojica JJ, Nairizi A, George SJ. 2014, Sep-Oct. Patient perception of pain care in the United States: a 5-year comparative analysis of hospital consumer assessment of health care providers and systems. Pain Physician. 17(5):369-77.",
241,PresComReport,36,315,Article,,10.4103/0974-2700.179454,,27162437,,"Kelly S, Johnson GT, Harbison RD. 2016, Apr-Jun. ""Pressured to prescribe"" The impact of economic and regulatory factors on South-Eastern ED physicians when managing the drug seeking patient. J Emerg Trauma Shock. 9(2):58-63.",
242,PresComReport,37,365,Article,,/10.15585/mmwr.mm6643e1.,WOS:000414252200007,,,"O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016. MMWR Morb Mortal Wkly Rep. ePub: 27 October 2017. DOI: http://dx.doi.org/10.15585/mmwr.mm6643e1.",
243,PresComReport,38,303,Website,,,,,,https://www.dea.gov/divisions/hq/2016/hq100416.shtml,
244,PresComReport,39,398,Report,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 1.28A and 1.28B. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
245,PresComReport,40,285,Article,,,WOS:000409120400003,28761945,,"Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. 2017. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med 167(5):293-301.",
246,PresComReport,41,285,Article,,,WOS:000409120400003,28761945,,"Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. 2017. Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med 167(5):293-301.",
247,PresComReport,42,232,Report,,,,,Not found in WOS,"Center for Behavioral Health Statistics and Quality. (2016). Key substance use and mental health indicators in the United States: Results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16 - 4984, NSDUH Series H-51). Retrieved from http://www.samhsa.gov/data/.",
248,PresComReport,43,398,Report/Website/Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Section 1 Tables and Table 5.17A. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
249,PresComReport,44,398,Report/Website/Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Section 5 Tables. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
250,PresComReport,45,346,Article,,,WOS:000251185000011,17916222,,"McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. 2007. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction. 102(12):1920–30",
251,PresComReport,46,399,Article,,,WOS:000241467500004,17060538,,"Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. 2006. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 166(19):2087–93.",
252,PresComReport,47,213,Article,,,WOS:000289507500027,21354703,,"Barry DT, Goulet JL, Kerns RK, Becker WC, Gordon AJ, Justice AC, Fiellin DA. 2011, May. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 152(5):1133-8.",
253,PresComReport,48,276,Article,,,WOS:000344456900002,25115224,,"Galanter M, Dermatis H, Sampson C. 2014. Narcotics anonymous: a comparison of military veterans and nonveterans. J Addict Dis. 33(3):187-95.",
254,PresComReport,49,313,Article,,,WOS:000072660700009,9547764,,"Kaltenbach K, Berghella V, Finnegan L. 1998. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 25(1):139–51.",
255,PresComReport,50,216,Article,,,WOS:000253929700005,18063321,,"Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. 2008. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 94(1–3):38–47.",
256,PresComReport,51,398,Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 1.28A and 1.28B. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
257,PresComReport,52,423,Article,,,WOS:000390965200018,27810654,,"Wu LT, Zhu H, Swartz MS. 2016, Dec 1. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 169:117-127.",
258,PresComReport,53,314,Article,,,WOS:000384981200035,27196642,,"Katzman JG, Fore C, Bhatt S, Greenberg N, Griffin Salvador J, Comerci GC, Camarata C, Marr L, Monette R, Arora S, Bradford A, Taylor D, Dillow J, Karol S. 2016, Aug. Evaluation of American Indian Health Service Training in Pain Management and Opioid Substance Use Disorder. Am J Public Health. 106(8):1427-9.",
259,PresComReport,54,365,Article,,/10.15585/mmwr.mm6643e1,WOS:000414252200007,,,"O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016. MMWR Morb Mortal Wkly Rep. ePub: 27 October 2017. DOI: http://dx.doi.org/10.15585/mmwr.mm6643e1",
260,PresComReport,55,329,Article,,,WOS:000409184600001,28459969,,"Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. 2017. Reports of adverse events associated with use of novel psychoactive substances, 2013-2016: A review. J Anal Toxicol 41(7):573-610.",
261,PresComReport,56,245,Article,,,WOS:000407666100014,28582697,,"Cicero TJ, Ellis MS, Kasper ZA. Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids. Drug Alcohol Depend. 2017 Aug 1;177:101-103.",
262,PresComReport,57,365,Article,,/10.15585/mmwr.mm6643e1,WOS:000414252200007,,,"O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016. MMWR Morb Mortal Wkly Rep. ePub: 27 October 2017. DOI: http://dx.doi.org/10.15585/mmwr.mm6643e1",
263,PresComReport,58,317,Article,,,WOS:000384275600006,,,"Klar SA, Brodkin E, Gibson E, Padhi S, Predy C, Green C, Lee V. Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine - British Columbia, Canada, July 15-18, 2016. MMWR Morb Mortal Wkly Rep. 2016 Sep 23;65(37):1015-1016.",
264,PresComReport,59,267,Article,,,WOS:000406260800051,28740128,,"Fabregat-Safont D, Carbón X, Ventura M, Fornís I, Guillamón E, Sancho JV, Hernández F, Ibáñez M. 2017. Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4 - dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900). Sci Rep 7(1):6338.",
265,PresComReport,60,425,Article,,,WOS:000404781900001,28713291,,Zawilska JB. An Expanding World of Novel Psychoactive Substances: Opioids. Front Psychiatry. 2017 Jun 30;8:110. doi: 10.3389/fpsyt.2017.00110. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL,
266,PresComReport,61,272,Article,,,WOS:000404528000002,28035035,,"Fleming SW, Cooley JC, Johnson L, Frazee CC, Domanski K, Kleinschmidt K, Garg U. Analysis of U-47700, a Novel Synthetic Opioid, in Human Urine by LC-MS-MS and LC-QToF. J Anal Toxicol. 2017 Apr 1;41(3):173- 0.",
267,PresComReport,62,374,Article,,,WOS:000406998300004,28590391,,"Prekupec MP, Mansky PA, Baumann MH. Misuse of Novel Synthetic Opioids: A Deadly New Trend. J Addict Med. 2017 Jul/Aug;11(4):256-265.",
268,PresComReport,63,409,Article,,10.2174/1874467210666170704110146,,28676005,,"Ventura L, Carvalho F, Dinis-Oliveira RJ. 2017. Opioids in the frame of new psychoactive substances network: A complex pharmacological and toxicological issue. Curr Mol Pharmacol [Epub ahead of print].",
269,PresComReport,64,391,Article,,,WOS:000408302900010,28708940,,"Soares JX, Alves EA, Silva AMN, de Figueiredo NG, Neves JF, Cravo SM, Rangel M, Netto ADP, Carvalho F, Dinis-Oliveira RJ, Afonso CM. 2017. Street-like synthesis of Krokodil Results in the formation of an enlarged cluster of known and new morphinans. Chem Res Toxicol 30(8):1609-1621.",
270,PresComReport,65,398,Report/Website/Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 1.28A. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf on October 25, 2017.",
271,PresComReport,66,243,Article,,,WOS:000390074000038,27544696,,"Cicero TJ, Ellis MS, Kasper ZA. Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers. Addict Behav. 2017 Feb;65:242-244.",
272,PresComReport,67,311,Article,,,WOS:000410935700053,28640680,,"Jarlenski M, Barry CL, Gollust S, Graves AJ, Kennedy-Hendricks A, Kozhimannil K. Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons. Am J Public Health. 2017 Aug;107(8):1308-1310.",
273,PresComReport,68,345,Article,,10.1002/hup.2625,,28750478,,"McCabe SE, West BT, Jutkiewicz EM, Boyd CJ. Multiple DSM-5 substance use disorders: A national study of US adults. Hum Psychopharmacol. 2017 Sep;32(5). [e-pub July 2017]",
274,PresComReport,69,286,Article,,,WOS:000362647800014,26461997,,"Han B, Compton WM, Jones CM, Cai R. 2015. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA 314(14):1468-78.",
275,PresComReport,70,227,Article,,,WOS:000371837200016,26785634,,"Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. 2016. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study. Drug Alcohol Depend 160:127- 34.",
276,PresComReport,71,249,Article,,,WOS:000253957600021,17581533,,"Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ. 2008. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 33(5):1179-91.",
277,PresComReport,72,388,Article,,,WOS:000414381400009,28711636,,"Shah A, Hayes CJ, Martin BC. 2017. Factors influencing long-term opioid use among opioid naive patients: An examination of initial prescription characteristics and pain etiologies. J Pain [Epub ahead of print].",
278,PresComReport,73,397,Article,,,WOS:000393267300007,28017184,,"Stumbo SP, Yarborough BJ, McCarty D, Weisner C, Green CA. 2017. Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. J Subst Abuse Treat 73:47-54.",
279,PresComReport,74,335,Article,,,WOS:000314461300002,22786464,,"Manchikanti L, Helm S II, Fellows B, et al. 2012. Opioid epidemic in the United States. Pain Physician 15:Suppl:ES9-38.",
280,PresComReport,75,206,Article,,,WOS:000390074000033,27639956,,"Arria AM, Compton WM. 2017. Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs. Addict Behav 65:215-217.",
281,PresComReport,76,227,Article,,,WOS:000371837200016,26785634,,"Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. 2016. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study. Drug Alcohol Depend 160:127- 34.",
282,PresComReport,77,252,Article,,,WOS:000367996700010,26760086,,"Compton WM, Jones CM, Baldwin GT. 2016. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 374(2):154-63.",
283,PresComReport,78,251,Article,,,WOS:000373085500026,27028930,,"Compton WM, Jones CM, Baldwin GT. 2016. Nonmedical prescription-opioid use and heroin use. N Engl J Med 374(13):1296.",
284,PresComReport,79,354,Report,,,,,,"Muhuri PK, Gfroerer JC, Davies C. 2013, August. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. Available at http://archive.samhsa.gov/data/2k13/DataReview/DR006/nonmedical-pain-reliever-use-2013.pdf.",
285,PresComReport,80,203,Article,,,WOS:000390074000035,27569698,,"Al-Tayyib AA, Koester S, Riggs P. 2017. Prescription opioids prior to injection drug use: Comparisons and public health implications. Addict Behav 65:224-228. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
286,PresComReport,81,252,Article,,,WOS:000367996700010,26760086,,"Compton WM, Jones CM, Baldwin GT. 2016. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 374(2):154-63.",
287,PresComReport,82,354,Report,,,,,,"Muhuri PK, Gfroerer JC, Davies C. 2013, August. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. Available at http://archive.samhsa.gov/data/2k13/DataReview/DR006/nonmedical-pain-reliever-use-2013.pdf",
288,PresComReport,83,235,Article,,,WOS:000363540200023,26054942,,"Cerdá M, Santaella J, Marshall BD, Kim JH, Martins SS. 2015. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: A national study. J Pediatr 167(3):605-12.",
289,PresComReport,84,302,Website/Data,,,,,,https://www.cdc.gov/vitalsigns/heroin/infographic.html#graphic,
290,PresComReport,85,242,Article,,,WOS:000407536100010,28582659,,"Cicero TJ, Ellis MS, Kasper ZA. 2017. Increased use of heroin as an initiating opioid of abuse. Addict Behav 74:63-66.",
291,PresComReport,86,243,Article,,,WOS:000390074000038,27544696,,"Cicero TJ, Ellis MS, Kasper ZA. 2017. Psychoactive substance use prior to the development of iatrogenic opioid abuse: A descriptive analysis of treatment-seeking opioid abusers. Addict Behav 65:242-244.",
292,PresComReport,87,340,Article,,,WOS:000400464300008,28355458,,"Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. 2017. Changes in lifetime heroin use and heroin use disorder: Prevalence from the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 74(5):445-455",
293,PresComReport,88,242,Article,,,WOS:000407536100010,28582659,,"Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addict Behav. 2017 Nov;74:63-66",
294,PresComReport,89,292,Article,,,WOS:000351441700003,25747921,,"Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89.",
295,PresComReport,90,263,Article,,,WOS:000285205000009,21054613,,"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011 Jan;106(1):32-51.",
296,PresComReport,91,380,Article,,,WOS:000184494700007,12873239,,"Robins LN, Slobodyan S. Post-Vietnam heroin use and injection by returning US veterans: clues to preventing injection today. Addiction 2003; 98: 1053–60.",
297,PresComReport,92,379,Article,,,WOS:A1974S718200001,4818714,,"Robins LN, Davis DH, Goodwin DW. Drug use by U.S. Army enlisted men in Vietnam: a follow-up on their return home. Am J Epidemiol 1974; 99: 235–49.",
298,PresComReport,93,282,Article,,,WOS:000296173800024,21549528,,"Grella CE, Lovinger K. 30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California. Drug Alcohol Depend 2011; 118: 251–8.",
299,PresComReport,94,294,Article,,,WOS:000245291600007,17439868,,Hser YI. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis 2007; 26: 51–60.,
300,PresComReport,95,386,Article,,,WOS:000257232300005,18543361,,"Scherbaum N, Specka M. Factors influencing the course of opiate addiction. Int J Methods Psychiatr Res 2008; 17 suppl 1: S39–44.",
301,PresComReport,96,292,Article,,,WOS:000351441700003,25747921,,"Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89.",
302,PresComReport,97,414,Article,,,WOS:A1983QU97900005,,,Waldorf D. Natural recovery from opiate addiction: some social-psychological processes of untreated recovery. J Drug Issues 1983; 13: 237–80.,
303,PresComReport,98,292,Article,,,WOS:000351441700003,25747921,,"Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89.",
304,PresComReport,99,378,Article,,,WOS:000369518300011,26428361,,"Ries R, Krupski A, West II, Maynard C, Bumgardner K, Donovan D, Dunn C, Roy-Byrne P. 2015. Correlates of opioid use in adults with self-reported drug use recruited rrom public safety-neet primary care clinics. J Addict Med 9(5):417-26.",
305,PresComReport,100,347,Article,,,WOS:000390074000045,27575980,,"McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. 2017. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addict Behav 65:283-288.",
306,PresComReport,101,384,Article,,,WOS:A1996VL99200014,8902071,,"Scheidegger C, Zimmerli W. Incidence and spectrum of severe medical complications among hospitalized HIVseronegative and HIV seropositive narcotic drug users. AIDS 1996;10:1407–14. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
307,PresComReport,102,381,Article,,,WOS:000375796700012,27140989,,"Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/ dependence and associated serious infections increased sharply, 2002–12. Health Aff (Millwood) 2016;35:832–7.",
308,PresComReport,103,402,Article,,,WOS:000344646700010,25114031,,"Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, Hamdounia SB, Church DR, Barton K, Fisher C, Macomber K, Stanley M, Guilfoyle SM, Sweet K, Liu S, Iqbal K, Tohme R, Sharapov U, Kupronis BA, Ward JW, Holmberg SD. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis. 2014 Nov 15;59(10):1411-9.",
309,PresComReport,104,271,Article,,,WOS:000402875400001,28594786,,"Fleischauer AT, Ruhl L, Rhea S, Barnes E. 2017. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015. Morb Mortal Wkly Rep 66(22):569-573.",
310,PresComReport,105,223,Article,,,WOS:000340173600001,24990587,,"Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.",
311,PresComReport,106,209,Article,,,WOS:000311500500008,23052964,,"Bach AG, Jordan B, Wegener NA, Rusner C, Kornhuber M, Abbas J, Surov A. 2012. Heroin spongiform leukoencephalopathy (HSLE). Clin Neuroradiol 22(4):345-9.",
312,PresComReport,107,219,Article,,10.1097/01.rmr.0000192154.34563.6b,,16340648,,"Borne J, Riascos R, Cuellar H, Vargas D, Rojas R. 2005. Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging 16(3):239-45.",
313,PresComReport,108,268,Article,,,WOS:000399659500003,28095255,,"Fareed A, Kim J, Ketchen B, Kwak WJ, Wang D, Shongo-Hiango H, Drexler K. 2017. Effect of heroin use on changes of brain functions as measured by functional magnetic resonance imaging, a systematic review. J Addict Dis 36(2):105-116.",
314,PresComReport,109,324,Article,,,WOS:000392356700014,27742371,,"Lefaucheur R, Lebas A, Gérardin E, Grangeon L, Ozkul-Wermester O, Aubier-Girard C, Martinaud O, Maltête D. 2017. Leucoencephalopathy following abuse of sniffed heroin. J Clin Neurosci 35:70-72.",
315,PresComReport,110,253,Article,,,WOS:000406975400012,28612362,,"Corr TE, Hollenbeak CS. 2017. The economic burden of neonatal abstinence syndrome in the United States. Addiction 112(9):1590-1599.",
316,PresComReport,111,253,Article,,,WOS:000406975400012,28612362,,"Corr TE, Hollenbeak CS. The economic burden of neonatal abstinence syndrome in the United States. Addiction. 2017 Sep;112(9):1590-1599.",
317,PresComReport,112,225,Article,,,WOS:000289685900011,21199058,,"Callaghan T, Crimmins J, Schweitzer RD. Children of substance-using mothers: child health engagement and child protection outcomes. J Paediatr Child Health. 2011;47(4):223–227.",
318,PresComReport,113,237,Report,,,,,,"Child Welfare Information Gateway. 2016. Parental Drug Use as Child Abuse. U.S. Department of Health and Human Services, Children’s Bureau. Washington, DC. Accessed at https://www.childwelfare.gov/pubPDFs/drugexposed.pdf on October 25, 2017.",
319,PresComReport,114,392,Article,,,,22455509,,"Solis JM, Shadur JM, Burns AR, Hussong AM. Understanding the diverse needs of children whose parents abuse substances. Curr Drug Abuse Rev. 2012Jun;5(2):135-47.",
320,PresComReport,115,320,Report,,,,,,"Krueger, AB. 2017. Where Have All The Workers Gone? An Inquiry into the Decline of the U.S. Labor Force Participation Rate. Brookings Papers on Economic Activity. Accessed at https://www.brookings.edu/wpcontent/uploads/2017/09/1_krueger.pdf on October 25, 2017.",
321,PresComReport,116,257,Article,,,WOS:000383999900003,27623005,,"Curtis S. Florence, Chao Zhou, Feijun Luo, Likang Xu. 2016. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care 54 (10): 901",
322,PresComReport,117,230,Report/Website/Data,,,,,,"CDC National Center for Health Statistics. 2017. Provisional Counts of Drug Overdose Deaths, as of 8/6/2017. Accessed at https://www.cdc.gov/nchs/data/health_policy/monthly-drug-overdose-death-estimates.pdf on September 5, 2017.",
323,PresComReport,118,222,Article,,10.1186/s40621-017-0118-7,,28762157,,"Brady JE, Giglio R, Keyes KM, DiMaggio C, Li G. 2017. Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis. Inj Epidemiol 4(1):24.",
324,PresComReport,119,222,Article,,10.1186/s40621-017-0118-7,,28762157,,"Brady JE, Giglio R, Keyes KM, DiMaggio C, Li G. 2017. Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis. Inj Epidemiol 4(1):24.",
325,PresComReport,120,365,Article,,/10.15585/mmwr.mm6643e1 ,WOS:000414252200007,,,"O’Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016. MMWR Morb Mortal Wkly Rep. ePub: 27 October 2017. DOI: http://dx.doi.org/10.15585/mmwr.mm6643e1 DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
326,PresComReport,121,260,Data,,,,,,"Data on facilities from the Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services information on the Behavioral Health Treatment Services Locator, available at https://findtreatment.samhsa.gov/. Extracted by ONDCP on February 10, 2016; county levels of urbanization are from the National Center for Health Statistics classification.",
327,PresComReport,122,261,Data,,,,,,"Data on physicians from the Drug Enforcement Administration, unpublished data provided to ONDCP as of February 16, 2016; county levels of urbanization are from the National Center for Health Statistics classification.",
328,PresComReport,123,376,Article,,,WOS:000334997100013,24611820,,Pullen E and Oser C. 2014. Barriers to Substance Abuse Treatment in Rural and Urban Communities: Counselor Perspectives. Substance Use and Misuse 49:891-901.,
329,PresComReport,124,256,Article,,,WOS:000331370600011,24369387,,"Cummings JR, Wen H, Ko M, and Druss BG. 2014. Race/Ethnicity and Geographic Access to Medicaid Substance Use Disorder Treatment Facilities in the United States. JAMA Psychiatry 71(2):190-196.",
330,PresComReport,125,417,Report,,,,,,"Washington State Institute for Public Policy (May 2017). Benefit-cost technical documentation. Olympia, WA. http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBenefitCostTechnicalDocumentation.pdf",
331,PresComReport,126,383,Article,,,WOS:000282710900002,20815663,,"Ryan SM, Jorm AF, Lubman DI. 2010. Parenting factors associated with reduced adolescent alcohol use: a systematic review of longitudinal studies. Aust N Z J Psychiatry 44:774–783.",
332,PresComReport,127,205,Article,,,WOS:000242791000012,17176385,,"an der Vorst H, Engels RC, Meeus W, Dekovic M. 2006. The impact of alcohol-specific rules, parental norms about early drinking and parental alcohol use on adolescents' drinking behavior. J Child Psychol Psychiatry;47:1299–1306.",
333,PresComReport,128,360,Report,,,,,,National Survey of American Attitudes on Substance Abuse XVI: Teens and Parents; National Center on Addiction and Substance Abuse at Columbia University; August 2011.,
334,PresComReport,129,369,?,,,,,,"PATS, 2011.",
335,PresComReport,130,398,Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 6.53B. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
336,PresComReport,131,398,Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 3.29B. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
337,PresComReport,132,398,Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 3.29B. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
338,PresComReport,133,390,Article,,,WOS:000259560600001,18485621,,"Smit E, Verdurmen J, Monshouwer K, Smit F. 2008. Family interventions and their effect on adolescent alcohol use in general populations; a meta-analysis of randomized controlled trials. Drug Alcohol Depend 97:195–206.",
339,PresComReport,134,349,Article,,,WOS:000275809700014,,,"Mednick SC, Christakis NA, Fowler JH. The spread of sleep loss influences drug use in adolescent social networks. PLoS One. 2010 Mar 19;5(3):e9775.",
340,PresComReport,135,363,Report,,,,,,"NIDA (2016). Principles of Substance Abuse Prevention for Early Childhood. Retrieved from https://www.drugabuse.gov/publications/principles-substance-abuse-prevention-early-childhood on 2017, September 6.",
341,PresComReport,136,221,Article,,,WOS:000271247700012,23766545,,"Bradshaw, C. P., Zmuda, J. H., Kellam, S. G., & Ialongo, N. S. 2009. Longitudinal impact of two universal preventive interventions in first grade on educational outcomes in high school. Journal of Educational Psychology 101(4), 926-937.",
342,PresComReport,137,290,Article,,,WOS:000079019600003,10086398,,"Hawkins, J. D., Catalano, R. F., Kosterman, R., Abbott, R., & Hill, K. G. 1999. Preventing Adolescent HealthRisk Behaviors by Strengthening Protection During Childhood. Archives of Pediatrics & Adolescent Medicine 153(3).",
343,PresComReport,138,288,Article,,,WOS:A1967A134300010,6054183,,"Hawkins, D. 1967. On Understanding the Understanding of Children. Archives of Pediatrics & Adolescent Medicine, 114(5), 513. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
344,PresComReport,139,289,Article,,,,,Not found in WoS,"Hawkins, J. D., Arthur, M. W., & Catalano, R. F. 1995. Preventing substance abuse. Crime and Justice: A Review of Research, 19, 343-428.",
345,PresComReport,140,394,Article,,,WOS:000257731300007,20376279,,"Spoth, R., Randall, G. K., & Shin, C. 2008. School Psychology Quarterly, 23(1), 70-89",
346,PresComReport,141,321,Article,,,WOS:000301789300005,22108900,,"Kuklinski, Margaret R., et al. 2012. ""Cost-benefit analysis of Communities That Care outcomes at eighth grade."" Prevention Science 13.2: 150-161.",
347,PresComReport,142,328,Article,,,WOS:000180016100014,12549711,,"Lockman, J. E., & Wells, K. C. 2002. Contextual social–cognitive mediators and child outcome: A test of the theoretical model in the Coping Power program. Development and Psycho.pathology, 14(04), 945-967.",
348,PresComReport,143,229,Book,,10.1016/B978-012369429-4/50041-0,,,Not found in WoS,"Catalano, R. F., Haggerty, K. P., Fleming, C. B., & Skinner, M. L. (2007). Focus on Families. Therapist's Guide to Evidence-Based Relapse Prevention, 237-257.",
349,PresComReport,144,363,Website,,,,,,"NIDA. 2016. Principles of Substance Abuse Prevention for Early Childhood. Retrieved from https://www.drugabuse.gov/publications/principles-substance-abuse-prevention-early-childhood on 2017, September 6.",
350,PresComReport,145,291,Website,,,,,,"HHS. 2017. Facing Addiction in America. U. S. Surgeon General’s Report on Alcohol, Drugs, and Health. Retrieved from https://addiction.surgeongeneral.gov/.",
351,PresComReport,146,291,Website,,,,,,"HHS. 2017. Facing Addiction in America. U. S. Surgeon General’s Report on Alcohol, Drugs, and Health. Retrieved from https://addiction.surgeongeneral.gov/.",
352,PresComReport,147,333,Article,,,WOS:000277795700019,20201863,,"Madras BK. 2010, Feb. Office of National Drug Control Policy: a scientist in drug policy in Washington, DC. Ann N Y Acad Sci. 1187:370-402.",
353,PresComReport,148,318,Article,,,WOS:000250701400002,17984404,,"Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, Carey P, Kossack R, Kulig J. 2007, Nov. Prevalence of positive substance abuse screen results among adolescent primary care patients. Arch Pediatr Adolesc Med. 161(11):1035-41.",
354,PresComReport,149,377,Article,,,WOS:000400999800019,28328312,,"Ramos MM, Sebastian RA, Murphy M, Oreskovich K, Condon TP. 2017, Apr-Jun. Adolescent substance use: Assessing the knowledge, attitudes, and practices of a school-based health center workforce. Subst Abus. 38(2):230-236.",
355,PresComReport,150,287,Article,,,WOS:000372743900027,25774987,,"Harris BR, Shaw BA, Sherman BR, Lawson HA. 2016. Screening, brief intervention, and referral to treatment for adolescents: Attitudes, perceptions, and practice of New York school-based health center providers. Subst Abus. 37(1):161-7.",
356,PresComReport,151,353,Article,,,WOS:000355307700002,26017980,,"Mitchell AM, Fioravanti M, Kane I, Puskar K, Hagle H, Boucek L. 2015, Jun. A call for universal alcohol, drug screening. Am J Nurs. 115(6):11.",
357,PresComReport,152,270,Article,,,WOS:000183177000006,12773784,,"Farrelly, MC, Niederdeppe, J, & Yarsevich, J. (2003). Youth tobacco prevention mass media campaigns: Past, present, and future directions, BMJ: TC, Accessed at: http://tobaccocontrol.bmj.com/content/12/suppl_1/i35.",
358,PresComReport,153,279,Article,,,WOS:000334768400009,24745639,,"Gibson, LA, Parvanta, SA, Jeong, M, & Hornik RC. (2014). Evaluation of a mass media campaign promoting using help to quit smoking, American Journal of Preventive Medicine, 4(5): 487-495.",
359,PresComReport,154,259,Article,,,WOS:000385442700007,27664597,,"Das, JK, et al. (2016). Interventions for adolescent substance abuse: An overview of systematic reviews, Journal of Adolescent Health, 59: s61-75.",
360,PresComReport,155,385,Article,,,WOS:000277574300002,20432107,,"Scheier LM and Grenard JL (2010). Influence of a nationwide social marketing campaign on adolescent drug use, Journal of Health Communication, 12(3) 240-271.",
361,PresComReport,156,366,Report,,,,,,"Orwin, R. Cadell, D, Chu, A, Kalton, G, Maklan, D, Morin, C, Piesse, A, Sridharan, S, Steele, D, Taylor, K, & Tracy, E. (2006). Evaluation of the National Youth Anti-Drug Media Campaign: 2004 Report of Findings, National Institutes of Health, National Institute on Drug Abuse; Bethesda, MD. Accessed at: https://archives.drugabuse.gov/initiatives/westat/NSPY2004Report/Vol1/Report.pdf",
362,PresComReport,157,202,Article,,10.1136/bmjopen-2014-007449.,WOS:000360863100032,26338836,,"Allara, E. et al. (2015). Are mass-media campaigns effecting in preventing drug use? A Cochrane systematic review and meta-analysis, British Medical Journal Open, 5:e007449.doi:10.1136/bmjopen-2014-007449.",
363,PresComReport,158,,Article,,10.1080/10510970209388598,,,,"Stephenson, MT. (2009). Sensation seeking as a moderator of the processing of anti-heroin PSA’s, Journal of Communication Studies, 53(4): 358-380.",
364,PresComReport,159,368,Article,,,WOS:000170344900020,11211642,,"Palmgreen, P., Donohew, L, Lorch, EP, Hoyle, RH, & Stephenson, MT, (2001). Television campaigns and adolescent marijuana use: Tests of sensation seeking targeting, American Journal of Public Health, 91, 292-296. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
365,PresComReport,160,269,Article,,,WOS:000392900800002,28103214,,"Farrelly MC, Duke JC, Nonnemaker J, et al. Association Between The Real Cost Media Campaign and Smoking Initiation Among Youths — United States, 2014–2016. MMWR Morb Mortal Wkly Rep 2017;66:47–50. DOI: http://dx.doi.org/10.15585/mmwr.mm6602a2",
366,PresComReport,161,361,Personal Communication,,,,,,"Neil Seeman, personal communication",
367,PresComReport,162,362,Article,,,WOS:000401238500009,28334456,,"Newton NC, Champion KE, Slade T, Chapman C, Stapinski L, Koning, Tonks Z, Teesson M. 2017, May. A systematic review of combined student- and parent-based programs to prevent alcohol and other drug use among adolescents. Drug Alcohol Rev. 36(3):337-351.",
368,PresComReport,163,234,Article,,,WOS:000379357900013,27301691,,"Centers For Disease Control And Prevention Public Health Service U S Department Of Health And Human Services. Guideline for Prescribing Opioids for Chronic Pain. J Pain Palliat Care Pharmacother. 2016, Jun;30(2):138-40.",
369,PresComReport,164,357,Report,,,,,,"National Academies of Sciences, Engineering, and Medicine. 2017. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. Washington, DC: The National Academies Press. Page 70. doi: https://doi.org/10.17226/24781.",
370,PresComReport,165,284,Article,,10.15585/mmwr.mm6626a4,WOS:000404865800004,28683056,,"Guy,GP, Zhang, K, Bohm, MK, Losby, J, Lewis, B, Young, R, Murphy, LB, & Dowell, D. (2017). Vital signs: Changes in opioid prescribing in the United States, 2006-2015. Morbidity and Mortality Weekly (MMWR). 66(26); 697-704.",
371,PresComReport,166,407,Report,,,,,,VA and DoD. (2017). VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain. Version 3.0. Retrieved at https://www.healthquality.va.gov/guidelines/pain/cot/.,
372,PresComReport,167,299,Website,,,,,,https://www.ama-assn.org/delivering-care/reversing-opioid-epidemic,
373,PresComReport,168,300,Website,,,,,,https://www.asam.org/education/resources/Opioid-Prescribing,
374,PresComReport,169,295,Website,,,,,,http://www.aafp.org/patient-care/clinical-recommendations/all/opioid-prescribing.html,
375,PresComReport,170,297,Website,,,,,,https://pcss-o.org/,
376,PresComReport,171,308,Website,,,,,,https://www.samhsa.gov/medication-assisted-treatment/training-resources/opioid-courses,
377,PresComReport,172,304,Website,,,,,,https://www.drugabuse.gov/nidamed-medical-health-professionals/tool-resources-your-practice/other-opioidprescribing-resources,
378,PresComReport,173,358,Website,,,,,,"National Governor’s Association. 2016, July. A Compact to Fight Opioid Addiction. Retrieved at https://www.nga.org/cms/news/2016/opioid-compact.",
379,PresComReport,174,336,Article,,,,,Not found in WoS,"Marcus, P.A., Thomas, A.L. (2017). Prudent Prescribing: An Overview of Recent Federal and State Guidelines for Opioid Prescriptions. American Bar Association Health eSource. Opioid Epidemic Special Edition. 13(12). Retrieved at https://www.americanbar.org/publications/aba_health_esource/2016- 2017/opioids/prescriptions.html.",
380,PresComReport,175,204,Legislation,,,,,,"An Act Relative to Substance Use, Treatment, Education and Prevention. Chapter 52. Massachusetts Session Law. 2016. Retrieved at https://malegislature.gov/Laws/SessionLaws/Acts/2016/Chapter52.",
381,PresComReport,176,395,Legislation,,,,,,State of Washington Department of Health. WSR-11-12-025. Permanent Rules. Medical Quality Assurance Commission. Retrieved at http://apps.leg.wa.gov/documents/laws/wsr/2011/12/11-12-025.htm.,
382,PresComReport,177,220,Press Article,,,,,,Boston Globe and Harvard T.H. Chan School of Public Health. Prescription painkiller abuse: Attitudes among adults in Massachusetts and the United States. May 2015. https://cdn1.sph.harvard.edu/wpcontent/uploads/sites/21/2015/05/Prescription-Painkiller-Poll-Report.pdf.,
383,PresComReport,178,250,Data,,,,,,Commonwealth of Massachusetts Department of Public Health. Stop addiction in its tracks: Current statistics. 2016. http://www.mass.gov/eohhs/gov/departments/dph/stop-addiction/current-statistics.html.,
384,PresComReport,179,208,Article,,,WOS:A1982NY22700002,7091173,,"Avorn J, Chen M, Hartley R. 1982, Jul. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 73(1):4-8.",
385,PresComReport,180,212,Article,,,WOS:000374289300025,26978601,,"Baker JA, Avorn J, Levin R, Bateman BT. 2016, Apr 19. Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010. JAMA. 315(15):1653-4.",
386,PresComReport,181,215,Article,,,WOS:000382495100033,26996986,,"Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA, Landon JE, Rathmell JP, Huybrechts KF, Fischer MA, Choudhry NK. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women. Am J Obstet Gynecol. 2016 Sep;215(3):353.e1-353.e18. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
387,PresComReport,182,424,Website,,,,,,www.DrugEpi.org,
388,PresComReport,183,280,Article,,,,,No found ,"Gilson, AM. (2009). Pharmacists and controlled substances prescriptions, Medscape, Accessed at: http://www.medscape.com/viewarticle/701794",
389,PresComReport,184,356,Article,,,WOS:000405276600008,28738683,,"Nam YH, Shea DG, Shi Y, Moran JR. 2017, May. State prescription drug monitoring programs and fatal drug overdoses. Am J Manag Care. 23(5):297-303.",
390,PresComReport,185,239,Personal Communication,,,,,,"Christina Cook, Lekan Wang, Alex Boras (Palantir) personal communication, June 2017.",
391,PresComReport,186,310,Report,,,,,,"IMS Health, National Prescription Audit (NPATM). Cited in internal document: Preliminary Update on Opioid Pain Reliever (OPR) Prescription Rates Nationally and by State: 2010-2013.",
392,PresComReport,187,327,Report,,,,,Not found in WoS,"Lipari, R.N. and Hughes, A. How people obtain the prescription pain relievers they misuse. The CBHSQ Report: January 12, 2017. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD.",
393,PresComReport,188,296,Website,,,,,,http://www.hcahpsonline.org/home.aspx,
394,PresComReport,189,307,Website,,,,,,https://www.medicare.gov/hospitalcompare/about/what-is-HOS.html,
395,PresComReport,190,426,?,,,,,,  ,
396,PresComReport,191,312,Article,,10.1001/jamainternmed.2016.2737.,WOS:000379039700025,27294595,,"Jena AB1, Goldman D2, Karaca-Mandic P3. 2016, Jul 1. Hospital Prescribing of Opioids to Medicare Beneficiaries JAMA Intern Med. 176(7):990-7. doi: 10.1001/jamainternmed.2016.2737.",
397,PresComReport,192,312,Article,,10.1001/jamainternmed.2016.2737.,WOS:000379039700025,27294595,,"Jena AB1, Goldman D2, Karaca-Mandic P3. 2016, Jul 1. Hospital Prescribing of Opioids to Medicare Beneficiaries JAMA Intern Med. 176(7):990-7. doi: 10.1001/jamainternmed.2016.2737.",
398,PresComReport,193,241,Article,,,,27042784,,"Chughtai M1, Jauregui JJ1, Mistry JB1, Elmallah RK1, Diedrich AM1, Bonutti PM2, Delanois R1, Mont MA1. 2016, Apr. What Influences How Patients Rate Their Hospital After Total Knee Arthroplasty? Surg Technol Int. 28:261-5.",
399,PresComReport,194,352,Article,,10.1016/j.arth.2016.03.060,WOS:000386747900009,27155998,,"Mistry JB, Chughtai M, Elmallah RK, Le S, Bonutti PM, Delanois RE, Mont MA. 2016, Nov. What Influences How Patients Rate Their Hospital After Total Hip Arthroplasty? J Arthroplasty. 31(11):2422-2425. doi: 10.1016/j.arth.2016.03.060. Epub 2016 Apr 13. PMID: 27155998.",
400,PresComReport,195,398,Data,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Table 7.2A. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017.",
401,PresComReport,196,420,Report,,,,,,"What America’s Users Spend on Illegal Drugs: 2000-2010, RAND for ONDCP, Fen 2014",
402,PresComReport,197,400,Press Article,,,,,,"Sullum, J., How Many Daily Heroin Users Are There In The U.S.? Somewhere Between 60,000 And 1 Million. Maybe., Forbes, March 10, 2014",
403,PresComReport,198,406,Data,,,,,,"U.S. Department of Justice, Drug Enforcement Administration. STARLiMS forensic drug chemistry database. Analysis by ONDCP on export through May 15, 2017. These counts are not representative off all seized fentanyl tablets and capsules in the United States (or specific geographic regions), but are representative of all evidence submitted and analyzed by DEA laboratories from domestic sources.",
404,PresComReport,199,322,Conference Proceeding,,,,,Not found in WoS,"Kyle Soska and Nicolas Christin, Measuring the Longitudinal Evolution of the Online Anonymous Marketplace Ecosystem, Carnegie Mellon University, August 13, 2015, Accessed on September 19, 2016, http://www.usinex.org/conference/usinexsecurity15/technical-sessions/presentation/soska.",
405,PresComReport,200,334,Article,,,WOS:000400464300006,28355456,,"Madras BK. The Surge of Opioid Use, Addiction, and Overdoses: Responsibility and Response of the US Health Care System. JAMA Psychiatry. 2017 May1;74(5):441-442.",
406,PresComReport,201,332,Article,,,WOS:000262700500031,18929451,,"Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009 Jan 1;99(1-3):280-95.",
407,PresComReport,202,364,Report,,,,,,"NIDA. 2012, December 1. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). Retrieved from https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-basedguide-third-edition on 2017, September 6 DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
408,PresComReport,203,281,Article,,,WOS:000282111300001,20557970,,"Glasner-Edwards, S., Rawson, R. 2010. Evidence-based practices in addiction treatment: Review and recommendations for public policy. Health Policy. 97. 93-104",
409,PresComReport,204,351,Article,,,WOS:000338761900002,,,"Miller, S. M., Moulton, S. 2014. Publicness in Policy Environments: A Multilevel Analysis of Substance Abuse Treatment Services, Journal of Public Administration Research and Theory, 2014, 24, 3, 553",
410,PresComReport,205,401,Personal Communication,,,,,,"Summary of treatment requirements provided by Dr, Shelly Greenfield, McLean Hospital.",
411,PresComReport,206,323,Article,,,WOS:000413167500035,,,"Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS One. 2017 Oct 17;12(10):e0186315.",
412,PresComReport,207,330,Article,,,WOS:000325234400007,23998769,,"Lorman, W.J. 2013. Maintaining Sobriety and Recovery, Nursing Clinics of North America, 2013, 48, 3, 437",
413,PresComReport,208,265,Article,,,WOS:000315568700001,23363550,,"Duffy, P., Baldwin, H. 2013. Recovery post treatment: plans, barriers and motivators, Substance Abuse Treatment, Prevention, and Policy, 2013, 8, 1, 6",
414,PresComReport,209,359,Report,,,,,,National Quality Forum. 2017. Behavioral Health 2016-2017: final Technical Report. https://www.qualityforum.org/Publications/2017/08/Behavioral_Health_2016-2017_Final_Report.aspx,
415,PresComReport,210,277,Report,,,WOS:000237401400003,16767849,,"Garnick, D., Horgan, C., & Chalk, M. 2006. Performance measures for alcohol and other drug services. Alcohol Research & Health, 29(1), 19-26Retrieved from https://pubs.niaaa.nih.gov/publications/arh291/19-26.htm",
416,PresComReport,211,207,Report,,,,,,ASAM. 2005.Principles for Outcome Evaluation in the Treatment of Substance-Related Disorders: a Joint AMBHA-ASAM Statement. Retrieved from https://www.asam.org/docs/default-source/public-policystatements/1outcome-evaluation-1-012.pdf?sfvrsn=0,
417,PresComReport,212,342,Article,,,WOS:000332082400003,24500948,,"Mattick, R.P., et al. 2014. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2): p. Cd002207.",
418,PresComReport,213,382,Article,,10.1155/2011/948789,WOS:000214595200023,21776440,,"Rosenblum, A., et al., Distance traveled and cross-state commuting to opioid treatment programs in the United States. J Environ Public Health, 2011. 2011: p. 948789.",
419,PresComReport,214,278,Article,,,WOS:000252964600018,18190664,,"Gibson, A., et al. 2008. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 103(3): p. 462-8.",
420,PresComReport,215,316,Article,,,WOS:000393734400001,28132694,,"Kermack, A., et al. 2017. Buprenorphine prescribing practice trends and attitudes among New York providers. J Subst Abuse Treat 74: p. 1-6.",
421,PresComReport,216,338,Article,,,WOS:000356026900001,25921475,,"Mark, T.L., et al., Medicaid coverage of medications to treat alcohol and opioid dependence. J Subst Abuse Treat, 2015. 55: p. 1-5.",
422,PresComReport,217,337,Article,,,WOS:000405246200016,28160345,,"Mardsen, J. et al. 2017. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. 112(8):1408-1418.",
423,PresComReport,218,214,Article,,,WOS:000307850300003,22873183,,"Bart, G. 2012. Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225.",
424,PresComReport,219,275,Article,,,WOS:000330257400005,24248468,,"Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., … Delphin-Rittmon, M. E. 2014. Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services, 65(2), 146–157.",
425,PresComReport,220,331,Article,,,WOS:000309661500001,23038795,,"MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman, M. 2012. Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945.",
426,PresComReport,221,421,Article,,,WOS:000338025800011,24751432,,"Woody, G. E., Bruce, D., Korthuis, P. T., Chhatre, S., Poole, S., Hillhouse, M., … Ling, W. 2014. HIV risk reduction with buprenorphine-naloxone or methadone: Findings from a randomized trial. Journal of Acquired Immune Deficiency Syndromes, 66(3), 288–293.",
427,PresComReport,222,422,Report,,,,,,"World Health Organization. 2009. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva, Switzerland: WHO Press.",
428,PresComReport,223,387,Article,,,WOS:000268058200008,19443133,,"Schwartz, R. P., Jaffe, J. H., O’Grady, K. E., Kinlock, T. W., Gordon, M. S., Kelly, S. M., Ahmed, A. 2009. Interim methadone treatment: Impact on arrests. Drug and Alcohol Dependence, 103(3), 148–154.",
429,PresComReport,224,393,Article,,,WOS:000310553200013,22845057,,"Soyka, M., Träder, A., Klotsche, J., Haberthür, A., Bühringer, G., Rehm, J., & Wittchen, H. U. (2012). Criminal behavior in opioid-dependent patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample. Journal of Forensic Sciences, 57(6), 1524–1530. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
430,PresComReport,225,274,Article,,,WOS:000302609500003,22263709,,"Friedmann PD, Hoskinson R, Jr, Gordon M, Schwartz R, et al. (2012). Medication-Assisted Treatment in criminal justice agencies affiliated with the Criminal Justice-drug Abuse Treatment Studies (CJ-DATS): Availability, barriers and intentions. Subst Abuse. 33:9–18.",
431,PresComReport,226,217,Article,,,WOS:000326187300011,24132733,,"Belenko, S. et al. (2013). Treating Substance Use Disorders in the Criminal Justice System. Curr Psychiatry Rep. 15(11).",
432,PresComReport,227,348,Article,,,WOS:000226662400005,,,"McMillan G.P., Lapham S.C. (2005). Staff perspectives on methadone maintenance therapy (MMT) in a large southwestern jail. Addict Res Theory. 13:53–63.",
433,PresComReport,228,233,Website/Data,,,,,Not found in WOS,"Center for Behavioral Health Statistics and Quality. 2017. Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 16- 4984, NSDUH Series H-51). Retrieved from http://www.samhsa.gov/data/(https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUHFFR1-2016.htm#tx1)",
434,PresComReport,229,339,Website/Data,,,,,,"Marlowe D, Hardin C, Fox C. 2016. Painting the Current Picture: A National Report on Drug Courts and Other Problem-Solving Courts in the United States, National Drug Court Institute. Alexandria, VA. Retrieved from https://www.ndci.org/wp-content/uploads/2016/05/Painting-the-Current-Picture-2016.pdf",
435,PresComReport,230,418,Report,,,,,,"Weiss AJ, Elixhauser A, Barrett ML, Steiner CA, Bailey MK, O’Malley L. Opioid Related Inpatient Stays and Emergency Department Visits by State, 20019-2014, HCUP Statistical Brief #219. December 2016. Agency for Healthcare Research and Quality. Rockville, MD.",
436,PresComReport,231,201,Report,,,,,Not found in WoS,"Ali, M. M., Mutter, R. (2016). The CBHSQ Report: Patients Who Are Privately Insured Receive Limited Followup Services After Opioid-Related Hospitalizations. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.",
437,PresComReport,232,398,Report,,,,,,"Substance Abuse and Mental Health Services Administration. 2017. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Retrieved from https://www.samhsa.gov/data/sites/default/files/NSDUHDetTabs-2016/NSDUH-DetTabs-2016.pdf, accessed on October 26, 2017",
438,PresComReport,233,309,Website,,,,,,https://www.whitehouse.gov/the-press-office/2017/06/15/presidential-executive-order-expanding-apprenticeshipsamerica,
439,PresComReport,234,415,Article,,,WOS:000375165000025,27012435,,"Walsh SL, Nuzzo PA, Babalonis S, Casselton V, Lofwall MR. 2016, May 1. Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers. Drug Alcohol Depend. 162:190-8.",
440,PresComReport,235,264,Article,,,WOS:000364433700012,26544739,,"Degenhardt L, Larance B, Peacock A, Farrell M. 2015, Nov 2. Reducing extramedical use and harms of pharmaceutical opioids: the potential role of abuse-deterrent formulations. Lancet Psychiatry. (11):957-9.",
441,PresComReport,236,298,Report,,,,,,https://static1.squarespace.com/static/57b13af320099e871dd94dc8/t/57c31e2fe4fcb561cb850b86/1472405052315 /2016+naloxone+coprescription.pdf,
442,PresComReport,237,319,Report,,,,,Not found in WoS,"Kortenkamp, K., and Ehrle, J. 2002. The well-being of children Involved with the child welfare system: A national overview, New Federalism, Series B, No. B-43. Washington, D.C.: The Urban Institute. ttp://www.urban.org/UploadedPDF/310413_anf_b43.pdf",
443,PresComReport,238,231,Article,,,WOS:000381451200002,27513154,,CDC. 2016 Morbidity and Mortality Weekly Report(MMWR) Incidence of Neonatal Abstinence Syndrome. Retrieved from https://www.cdc.gov/mmwr/volumes/65/wr/mm6531a2.htm,
444,PresComReport,239,228,Report,,,,,Not found in WoS,"Castedo, S. Holleran Steiker, L. (in press). Collegiate Recovery Programs. In Smith, D.C., (Ed.), Emerging Adults in Substance Use Disorder Treatment. New York: Oxford University Press.",
445,PresComReport,240,273,Report,,,,,Not found in WoS,"Forrest, C.E. (2016). Collateral Consequences of a Criminal Conviction: Impact on Corrections and Reentry. NIJ Update. Corrections Today. American Correctional Association",
446,PresComReport,241,404,Report,,,,,,The National Council of State Governments Justice Center. National Inventory of Collateral Consequences of Conviction. Website. https://niccc.csgjusticecenter.org/map/,
447,PresComReport,242,371,Article,,,WOS:000277582400006,20299175,,"Policin, D.L. et al. (2010). Sober Living Houses for Alcohol and Drug Dependence: 18- Month Outcomes. Journal of Substance Abuse Treatment. 38(4): 356–365.",
448,PresComReport,243,411,Article,,,WOS:000406295000015,28564549,,"Volkow ND, Collins FS. 2017, Jul 27. The Role of Science in Addressing the Opioid Crisis. N Engl J Med. 377(4):391-394. DRAFT/ADVISORY/CONSULTATIVE/DELIBERATIVE/CONFIDENTIAL",
449,PresComReport,244,411,Article,,,WOS:000406295000015,28564549,,"Volkow ND, Collins FS. The Role of Science in Addressing the Opioid Crisis. N Engl J Med. 2017 Jul 27;377(4):391-394.",
450,PresComReport,245,389,Article,,10.1146/annurev-pharmtox-010617-052534,,28968188,,Skolnick P. The Opioid Epidemic: Crisis and Solutions. Annu Rev Pharmacol Toxicol. 2017 Oct 2. [Epub ahead of print],
451,PresComReport,246,341,Article,,,WOS:000411321000003,28934186,,"Massey J, Kilkenny M, Batdorf S, Sanders SK, Ellison D, Halpin J, Gladden RM, Bixler D, Haddy L, Gupta R. 2017, Sep 22. Opioid Overdose Outbreak - West Virginia, August 2016. MMWR Morb Mortal Wkly Rep. 66(37):975-980",
452,PresComReport,247,412,Article,,,WOS:000336434000003,24758595,,"Volkow ND, Frieden TR, Hyde PS, Cha SS. 2014. Medication-assisted therapies — tackling the opioid-overdose epidemic. N Engl J Med 370: 2063-6.",
453,PresComReport,248,293,Article,,,WOS:000372907400022,26599131,,"Hser YI, Evans E, Huang D, Weiss R, Saxon A, Carroll KM, Woody G, Liu D, Wakim P, Matthews AG, HatchMaillette M, Jelstrom E, Wiest K, McLaughlin P, Ling W. 2016, Apr. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction. 111(4):695-705.",
454,PresComReport,249,419,Article,,,WOS:000400040500007,28363320,,"Weiss RD, Rao V. 2017, Apr 1. The Prescription Opioid Addiction Treatment Study: What have we learned. Drug Alcohol Depend. 173 Suppl 1:S48-S54.",
455,PresComReport,250,416,Article,,10.1109/ICCNC.2017.7876173,WOS:000402039800083,28993811,,"Wang J, Fang H, Carreiro S, Wang H, Boyer E. 2017, Jan. A New Mining Method to Detect Real Time Substance Use Events from Wearable Biosensor Data Stream. Int Conf Comput Netw Commun. 2017:465-470.",
456,PresComReport,251,305,Website,,,,,,https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm338566.htm,
457,PresComReport,252,224,Article,,,WOS:000374128400013,26845291,,"Califf RM, Woodcock J, Ostroff S. 2016. A Proactive Response to Prescription Opioid. Abuse N Engl J Med 374:1480-1485",
458,PresComReport,253,266,Report,,,,,,"Extended-Release and Long-Acting Opioid Analgesics shared system, Risk Evaluation and Mitigation Strategy (REMS), https://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM348818.pdf",
459,PresComReport,254,413,Article,,,WOS:000223246400030,15189164,,"Waldhoer M, Bartlett SE, Whistler JL. 2004. Opioid receptors. Annu Rev Biochem 73:953-90.",
460,PresComReport,255,255,Book,,,,,ISBN13: 9780674005853,"Courtwright, David. 2001. Dark Paradise: A history of Opiate Addiction in America. Harvard University Press.",
461,PresComReport,256,355,Book,,,,,ISBN10: 0195125096,"Musto, David F. 1999. The American Disease: Origins of Narcotic Control. Yale University Press.",
462,PresComReport,257,254,Article,,,WOS:000365354800002,26605925,,"Courtwright DT. 2015, Nov 26. Preventing and Treating Narcotic Addiction--Century of Federal Drug Control. N Engl J Med. 373(22):2095-7.",
1,GAO/GGD-97-42,1,9,Legislation,,,,,,"Anti-Drug Abuse Act of 1988, P.L. 100-690",
2,GAO/GGD-97-42,2,96,Report,,,,,Not found in WoS,"National Household Survey on Drug Abuse: Population Estimates 1995, Substance Abuse and Mental Health Services Administration, 1996.",
3,GAO/GGD-97-42,3,122,Report,,,,,Not found in WoS,"The National Drug Control Strategy, 1996. Office of National Drug Control Policy, Washington, D.C.",
4,GAO/GGD-97-42,4,95,Report,,,,,,"National Drug Control Strategy: 1996. Office of National Drug Control Policy, Washington, D.C.",
5,GAO/GGD-97-42,5,32,Report,GAO/GGD-88-39,,,,,"Controlling Drug Abuse: A Status Report (GAO/GGD-88-39, Mar. 1, 1988)",
6,GAO/GGD-97-42,6,41,Report,GAO/GGD-93-144,,,,,"Drug Control: Reauthorization of the Office of National Drug Control Policy (GAO/GGD-93-144, Sept. 29, 1993).",
7,GAO/GGD-97-42,7,41,Report,GAO/GGD-93-144.,,,,,GAO/GGD-93-144.,
8,GAO/GGD-97-42,8,40,Report,GAO/NSIAD-97-75,,,,,"Drug Control: Long-Standing Problems Hinder U.S. International Efforts (GAO/NSIAD-97-75, Feb. 27, 1997).",
9,GAO/GGD-97-42,9,41,Report,GAO/GGD-93-144.,,,,,GAO/GGD-93-144.,
10,GAO/GGD-97-42,10,63,Report,,,,,,"Institute of Medicine, Pathways of Addiction: Opportunities in Drug Abuse Research (Washington, D.C.: National Academy Press), 1996, pp. 141-145.",
11,GAO/GGD-97-42,11,69,Article,,,WOS:A1994NC03000002,,,"Kathleen Carroll and others, “Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers,” Archives of General Psychiatry, 51 (1994), 177-187.",
12,GAO/GGD-97-42,12,111,Article,,,WOS:A1993LA32300014,8480823,,"Stephen Higgins and others, “Achieving Cocaine Abstinence With a Behavioral Approach,” American Journal of Psychiatry, 150:5 (1993), 763-69.",
13,GAO/GGD-97-42,13,115,Article,,,WOS:A1994QM23100003,7734464,,"Stephen Shoptaw and others, “The Matrix Model of Outpatient Stimulant Abuse Treatment: Evidence of Efficacy,” Journal of Addictive Diseases, 13:4 (1994), 129-41.",
14,GAO/GGD-97-42,14,44,Report,GAO/GGD-95-159BR,,,,,"Drug Courts: Information on a New Approach to Address Drug-Related Crime (GAO/GGD-95-159BR, May 22, 1995).",
15,GAO/GGD-97-42,15,126,Report,GAO/GGD-94-128R,,,,,"Weed and Seed: Program Objectives (GAO/GGD-94-128R, May 10, 1994).",
16,GAO/GGD-97-42,16,42,Report,GAO/GGD-93-61,,,,,"Drug Control: Treatment Alternatives Program for Drug Offenders Needs Stronger Emphasis (GAO/GGD-93-61, Feb. 11, 1993).",
17,GAO/GGD-97-42,17,54,Report,GAO/NSIAD-97-75.,,,,,GAO/NSIAD-97-75.,
18,GAO/GGD-97-42,18,,Comment,,,,,,OMIT,
19,GAO/GGD-97-42,19,,Comment,,,,,,"OMIT  - According to officials at the Department of State, initial information indicates that, during 1996, significant reductions occurred in the amount of coca under cultivation in Peru.",
20,GAO/GGD-97-42,20,48,Report,GAO/T-NSIAD-95-194,,,,,"Drug War: Observations on U.S. International Drug Control Efforts (GAO/T-NSIAD-95-194, Aug. 1, 1995).",
24,GAO/GGD-97-42,22,38,Report,GAO/NSIAD-96-163,,,,,"Drug Control: Counternarcotics Efforts in Mexico (GAO/NSIAD-96-163, June 12, 1996).",
29,GAO/GGD-97-42,25,43,Report,GAO/NSIAD-96-119,,,,,"Drug Control: U.S.Interdiction Efforts in the Caribbean Decline (GAO/NSIAD-96-119, Apr. 17, 1996).",
30,GAO/GGD-97-42,26,32,Report,GAO/GGD-88-39,,,,,"Controlling Drug Abuse: A Status Report (GAO/GGD-88-39, Mar. 1, 1988).",
31,GAO/GGD-97-42,27,118,Report,GAO/NSIAD-92-226,,,,,"The Drug War: Extent of Problems in Brazil, Ecuador, and Venezuela (GAO/NSIAD-92-226, June 5, 1992).",
32,GAO/GGD-97-42,28,120,Report,GAO/NSIAD-92-36,,,,,"The Drug War: U.S. Programs in Peru Face Serious Obstacles (GAO/NSIAD-92-36, Oct. 21, 1991).",
33,GAO/GGD-97-42,29,124,Report,GAO/NSIAD-91-23,,,,,"The War on Drugs: Narcotics Control Efforts in Panama (GAO/NSIAD-91-233, June 16, 1991).",
34,GAO/GGD-97-42,30,39,Report,GAO/NSIAD-94-233,,,,,"Drug Control: Interdiction Efforts in Central America Have Had Little Impact on the Flow of Drugs (GAO/NSIAD-94-233, Aug. 2, 1994).",
35,GAO/GGD-97-42,31,48,Report,GAO/T-NSIAD-95-194,,,,,"Drug War: Observations on U.S. International Drug Control Efforts (GAO/T-NSIAD-95-194, Aug. 1, 1995).",
36,GAO/GGD-97-42,32,54,Report,GAO/NSIAD-97-75.,,,,,GAO/NSIAD-97-75.,
37,GAO/GGD-97-42,33,89,Report,GAO/GGD-94-73,,,,,"Money Laundering: U.S. Efforts to Fight It Are Threatened by Currency Smuggling (GAO/GGD-94-73, Mar. 9, 1994).",
38,GAO/GGD-97-42,34,13,Report,GAO/GGD-95-30,,,,,"Border Control: Revised Strategy Is Showing Some Positive Results (GAO/GGD-95-30, Dec. 29, 1994).",
39,GAO/GGD-97-42,35,62,Report,GAO/GGD-94-143,,,,,"INS Drug Task Force: Federal Agencies Supportive of INS Efforts (GAO/GGD-94-143, July 7, 1994).",
40,GAO/GGD-97-42,36,45,Report,GAO/GGD-91-10,,,,,"Drug Interdiction: Funding Continues to Increase but Program Effectiveness Is Unknown (GAO/GGD-91-10, Dec. 11, 1990).",
41,GAO/GGD-97-42,37,41,Report,GAO/GGD-93-144,,,,,"Drug Control: Reauthorization of the Office of National Drug Control Policy (GAO/GGD-93-144, Sept. 29, 1993).",
42,GAO/GGD-97-42,38,35,Report,GAO/GGD-96-189BR,,,,,"Customs Service: Drug Interdiction Efforts (GAO/GGD-96-189BR, Sept. 26, 1996).",
43,GAO/GGD-97-42,39,96,Report,,,,,Not found in WoS,"National Household Survey on Drug Abuse: Population Estimates 1995, Substance Abuse and Mental Health Services Administration, 1996.",
44,GAO/GGD-97-42,40,,Comment,,,,,,OMIT,
45,GAO/GGD-97-42,41,90,Report,,,,,Not found in WoS,"Monitoring the Future, National Institute on Drug Abuse, 1996.",
46,GAO/GGD-97-42,42,37,Report,GAO/HEHS-97-12,,,,,"Drug and Alcohol Abuse: Billions Spent Annually for Treatment and Prevention Activities (GAO/HEHS-97-12, Oct. 8, 1996).",
47,GAO/GGD-97-42,43,,Comment,,,,,,OMIT,
48,GAO/GGD-97-42,44,31,Report,GAO/HEHS-96-80,,,,,"Cocaine Treatment: Early Results From Various Approaches (GAO/HEHS-96-80, June 7, 1996).",
49,GAO/GGD-97-42,45,64,Unpublished document,,,,,,"Institute of Medicine, Treating Drug Problems, vol. 1 (Washington, D.C.: National Academy Press, 1990); Research Triangle Institute, Data Tables Comparing Crack and Cocaine Users to Other Drug Users Entering Drug Treatment, unpublished manuscript.",
65,GAO/GGD-97-42,47,127,Article,,,WOS:A1991FL87300008,1862062,,"William B. Hansen and John W. Graham, “Preventing Alcohol, Marijuana, and Cigarette Use Among Adolescents: Peer Pressure Resistance Training Versus Establishing Conservative Norms,” Preventive Medicine, 20 (1991), 414-30.",
70,GAO/GGD-97-42,50,6,Report,GAO/PEMD-92-2,,,,,"Adolescent Drug Use Prevention: Common Features of Promising Community Programs (GAO/PEMD-92-2, Jan. 16, 1992).",
71,GAO/GGD-97-42,51,,Comment,,,,,,OMIT,
72,GAO/GGD-97-42,52,31,Report,GAO/HEHS-96-80,,,,,"Cocaine Treatment: Early Results From Various Approaches (GAO/HEHS-96-80, June 7, 1996).",
87,GAO/GGD-97-42,53,69,Article,,,WOS:A1994NC03000002,,,"Kathleen Carroll et al., “Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers,” Archives of General Psychiatry, 51 (1994), 177-87.",
88,GAO/GGD-97-42,54,10,Monograph,,,,8289894,,"Arnold Washton and Nannette Stone-Washton, “Outpatient Treatment of Cocaine and Crack Addiction: A Clinical Perspective,” National Institute on Drug Abuse Research Monograph #135 (Rockville, Md.: National Institute on Drug Abuse, 1993), pp. 15-30.",
89,GAO/GGD-97-42,55,49,Article,,,WOS:A1994MY61500001,8192128,,"Elizabeth Wells et al., “Outpatient Treatment for Cocaine Abuse: A Controlled Comparison of Relapse Prevention and Twelve-Step Approaches,” American Journal of Drug and Alcohol Abuse, 20:1 (1994), 1-17.",
90,GAO/GGD-97-42,56,70,Article,,,WOS:A1991GB16900001,,,"Kathleen Carroll et al., “A Comparative Trial of Psychotherapies for Ambulatory Cocaine Abusers: Relapse Prevention and Interpersonal Psychotherapy,” American Journal of Drug and Alcohol Abuse, 17:3 (1991), 229-47.",
91,GAO/GGD-97-42,57,112,Article,,,WOS:A1991GD55200016,1883001,,"Stephen Higgins et al., “A Behavioral Approach to Achieving Initial Cocaine Abstinence,” American Journal of Psychiatry, 148:9 (1991), 1218-24.",
92,GAO/GGD-97-42,58,111,Article,,,WOS:A1993LA32300014,8480823,,"Stephen Higgins et al., “Achieving Cocaine Abstinence With a Behavioral Approach,” American Journal of Psychiatry, 150:5 (1993), 763-69.",
96,GAO/GGD-97-42,60,115,Article,,,WOS:A1994QM23100003,7734464,,"Steven Shoptaw et al., “The Matrix Model of Outpatient Stimulant Abuse Treatment: Evidence of Efficacy,” Journal of Addictive Diseases, 13:4 (1994), 129-41.",
97,GAO/GGD-97-42,61,106,Monograph,,,,8289906,,"Richard Rawson et al., “Neurobehavioral Treatment for Cocaine Dependency: A Preliminary Evaluation,” Cocaine Treatment: Research and Clinical Perspectives. National Institute on Drug Abuse Research Monograph #135 (Rockville, Md.: National Institute on Drug Abuse, 1993), pp. 92-115.",
100,GAO/GGD-97-42,63,114,Article,,,WOS:A1994QM23100004,7734465,,"Stephen Magura et al., “Neurobehavioral Treatment for Cocaine-Using Methadone Patients: A Preliminary Report,” Journal of Addictive Diseases, 13:4 (1994), 143-60.",
101,GAO/GGD-97-42,64,31,Report,GAO/HEHS-96-80,,,,,"Cocaine Treatment: Early Results From Various Approaches (GAO/HEHS-96-80, June 7, 1996).",
102,GAO/GGD-97-42,65,,Comment,,,,,,OMIT,
103,GAO/GGD-97-42,66,,Comment,,,,,,OMIT,
104,GAO/GGD-97-42,67,,Comment,,,,,,OMIT,
105,GAO/GGD-97-42,68,27,Comment,,,,,,Coast Guard officials,
106,GAO/GGD-97-42,69,27,Comment,,,,,,Coast Guard officials,
107,GAO/GGD-97-42,70,88,Report,,,,,,"Measuring Deterrence - Approach and Methodology, Rockwell International Special Investigations, Inc., Decisions Science Applications, Sumner Associates, Oct. 27, 1989.",
108,GAO/GGD-97-42,71,121,Report,,,,,Not found in WoS,"The National Drug Control Strategy, 1996: Program, Resources, and Evaluation. Office of National Drug Control Policy, Washington, D.C., pp. 48-51.",
109,GAO/GGD-97-42,72,51,Comment,,,,,,Findings - no citation,
110,GAO/GGD-97-42,73,,Comment,,,,,,OMIT,
21,GAO/GGD-97-42,21a,46,Report,GAO/NSIAD-91-296,,,,,"Drug War: Observations on Counternarcotics Aid to Colombia (GAO/NSIAD-91-296, Sept. 30, 1991);",
22,GAO/GGD-97-42,21b,120,Report,GAO/NSIAD-92-36,,,,,"The Drug War: U.S. Programs in Peru Face Serious Obstacles (GAO/NSIAD-92-36, Oct. 21, 1991);",
23,GAO/GGD-97-42,21c,116,Report,GAO/T-NSIAD-94-53,,,,,"The Drug War: Colombia Is Implementing Antidrug Efforts, but Impact Is Uncertain (GAO/T-NSIAD-94-53, Oct. 5, 1993).",
25,GAO/GGD-97-42,23a,119,Report,GAO/T-NSIAD-92-2,,,,,"The Drug War: Observations on Counternarcotics Programs in Colombia and Peru (GAO/T-NSIAD-92-2, Oct. 23, 1991)",
26,GAO/GGD-97-42,23b,117,Report,GAO/NSIAD-93-158,,,,,"The Drug War: Colombia Is Undertaking Antidrug Programs, but Impact Is Uncertain (GAO/NSIAD-93-158, Aug. 10, 1993).",
27,GAO/GGD-97-42,24a,47,Report,GAO/T-NSIAD-95-182,,,,,"Drug War: Observations on the U.S. International Drug Control Strategy (GAO/T-NSIAD-95-182, June 27, 1995)",
28,GAO/GGD-97-42,24b,38,Report,GAO/NSIAD-96-163,,,,,"Drug Control: Counternarcotics Efforts in Mexico (GAO/NSIAD-96-163, June 12, 1996).",
63,GAO/GGD-97-42,46a,57,Report,,,,,Not found in WoS,"Gilbert J. Botvin, “Preventing Adolescent Drug Abuse Through Life Skills Training: Intervention Approach and Evaluation Results,” Community Epidemiology Work Group (CEWG), June 1996, 451-459;",
64,GAO/GGD-97-42,46b,56,Article,,,WOS:A1995QR05900029,,,"Gilbert J. Botvin et al., “Long-term Follow-up Results of a Randomized Drug Abuse Prevention Trial in a White Middle-Class Population,” Journal of the American Medical Association, 273:14 (1995), 1106-12.",
66,GAO/GGD-97-42,48a,65,Unknown,,,,,,"J. David Hawkins and others, “Promoting Academic Success and Preventing Crime in Urban America: Six-Year Follow-Up Effects of the Seattle Social Development Project”",
67,GAO/GGD-97-42,48b,4,Unpublished document,,,,,,"a set of unpublished 6-year follow-up documents from Hawkins and others provided to us on November 28, 1996.",
68,GAO/GGD-97-42,49a,87,Unpublished document,,,,,,"Mary Ann Pentz,”Preventing Drug Abuse Through the Community: Multi-Component Programs Make the Difference”",
69,GAO/GGD-97-42,49b,86,Conference Proceeding,,,,,Not found in Wos,"Mary Ann Pentz “Benefits of Integrating Strategies in Different Settings,” in A. Elster, S. Panzarine, and K. Holt (eds.). American Medical Association State of the Art Conference on Adolescent Health Promotion Proceedings: National Center for Education in Maternal and Child Health, Arlington, VA, 1993, pp. 15-34.",
93,GAO/GGD-97-42,59a,67,Monograph ,,,,,Not found in WoS,"K. Silverman et al., “Differential Reinforcement of Sustained Cocaine Abstinence in Intravenous Polydrug Abusers,” in L. S. Harris (ed.), Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph 153 (Rockville, Md.: National Institute on Drug Abuse Research, 1995), p. 212,",
94,GAO/GGD-97-42,59b,68,Monograph ,,,,,Not found in WoS,"K. Silverman et al., “Voucher-Based Reinforcement of Cocaine Abstinence: Effects of Reinforcement Schedule,” in L. S. Harris (ed.), Problems of Drug Dependence 1995: Proceedings of the 57th Annual Scientific Meeting, The College on Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph, in press.",
95,GAO/GGD-97-42,59c,100,?,,,,,,"NIDA Notes, 10:5 (September-October 1995), 10 and 14.",
98,GAO/GGD-97-42,62a,7,Article,,,WOS:A1995RH46500004,7562262,,"Andrew Rosenblum et al., “Treatment Intensity and Reduction in Drug Use for Cocaine-Dependent Methadone Patients: A Dose Response Relationship.”",
99,GAO/GGD-97-42,62b,8,Conference Proceeding,,,,,Not found in Wos,"Andrew Rosenblum et al., “Treatment Intensity and Reduction in Drug Use for Cocaine-Dependent Methadone Patients: A Dose Response Relationship.” A prior version of this paper was presented at the American Society of Addiction Medicine Annual Conference, New York, New York, April 1994.",
50,GAO/GGD-97-42,Table II. 2: a.1,57,Report,,,,,Not found in WoS,"Gilbert J. Botvin, “Preventing Adolescent Drug Abuse Through Life Skills Training: Intervention Approach and Evaluation Results,” Community Epidemiology Work Group (CEWG), June 1996, 451-459;",
51,GAO/GGD-97-42,Table II. 2: a.2,56,Article,,,WOS:A1995QR05900029,,,"Gilbert J. Botvin et al., “Long-term Follow-up Results of a Randomized Drug Abuse Prevention Trial in a White Middle-Class Population,” Journal of the American Medical Association, 273:14 (1995), 1106-12.",
52,GAO/GGD-97-42,Table II. 2: b,103,Article,,,WOS:A1993KY30400007,8491635,,"Phyllis L. Ellickson, Robert M. Bell, and Ellen R. Harrison, “Changing Adolescent Propensities to Use Drugs: Results from Project ALERT,” Health Education Quarterly, 20:2 (summer 1993), 227-42.",
53,GAO/GGD-97-42,Table II. 2: c,55,Article,,,WOS:A1995RU67900005,,,"Gilbert J. Botvin et al., “Effectiveness of Culturally Focused and Generic Skills Training Approaches to Alcohol and Drug Abuse Prevention Among Minority Adolescents: Two-Year Follow-Up Results,” Psychology of Addictive Behaviors, 9:3 (1995), 183-94.",
54,GAO/GGD-97-42,Table II. 2: d,127,Article,,,WOS:A1991FL87300008,1862062,,"William B. Hansen and John W. Graham, “Preventing Alcohol, Marijuana, and Cigarette Use Among Adolescents: Peer Pressure Resistance Training Versus Establishing Conservative Norms,” Preventive Medicine, 20 (1991), 414-30.",
55,GAO/GGD-97-42,Table II. 2: e,80,Article,,,WOS:A1990EJ73100004,,,"Leona L. Eggert et al., “Effects of a School-Based Prevention Program for Potential High School Dropouts and Drug Abusers,” International Journal of the Addictions, 25:7 (1990), 773-801.",
56,GAO/GGD-97-42,Table II. 2: f.1,65,Unpublished document,,,,,,J. David Hawkins et al. entitled “Promoting Academic Success and Preventing Crime in Urban America: Six-Year Follow-Up Effects of the Seattle Social Development Project”,
57,GAO/GGD-97-42,Table II. 2: f.2,4,Unpublished document,,,,,,"a set of unpublished 6-year follow-up documents from Hawkins et al. provided to GAO on November 28, 1996.",
58,GAO/GGD-97-42,Table II. 2: g.1,87,Unpublished document,,,,,,Mary Ann Pentz entitled “Preventing Drug Abuse Through the Community: Multi-component Programs Make the Difference”,
59,GAO/GGD-97-42,Table II. 2: g.2,86,Unpublished document,,,,,,Mary Ann Pentz’s “Benefits of Integrating Strategies in Different Settings.”,
60,GAO/GGD-97-42,Table II. 2: h,52,Article,,/10.3109/10826089609045805,WOS:A1996UD34300002,8834005,,"G. Aktan, K. L. Kumpfer, and C. Turner, “The Safe Haven Program: Effectiveness of a Family Skills Training Program for Substance Abuse Prevention With Inner City African-American Families,” International Journal of the Addictions, 31 (1996), 158-75.",
61,GAO/GGD-97-42,Table II. 2: i,125,Article,,,WOS:A1995RL12800004,7673531,,"Thomas J. Dishion and David W. Andrews, “Preventing Escalation Problem Behaviors with High-Risk Young Adolescents: Immediate and 1-Year Outcomes,” Journal of Consulting and Clinical Psychology, 63:4 (1995), 538-48.",
62,GAO/GGD-97-42,Table II. 2: j,26,Article,,,WOS:A1996UX22100009,8669519,,"Cheryl L. Perry et al., “Project Northland: Outcomes of a Communitywide Alcohol Use Prevention Program During Early Adolescence,” American Journal of Public Health, 86:7 (1996), 956-65.",
73,GAO/GGD-97-42,Table II.3: a,69,Article,,,WOS:A1994NC03000002,,,"Kathleen Carroll et al., “Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers,” Archives of General Psychiatry, 51 (1994), 177-87.",
74,GAO/GGD-97-42,Table II.3: b,70,Article,,,WOS:A1991GB16900001,,,"Kathleen Carroll et al., “A Comparative Trial of Psychotherapies for Ambulatory Cocaine Abusers: Relapse Prevention and Interpersonal Psychotherapy,” American Journal of Drug and Alcohol Abuse, 17:3 (1991), 229-47.",
75,GAO/GGD-97-42,Table II.3: c,10,Monograph,,,,8289894,,"Arnold Washton and Nannette Stone-Washton, “Outpatient Treatment of Cocaine and Crack Addiction: A Clinical Perspective,” National Institute on Drug Abuse Research Monograph #135 (Rockville, Md.: National Institute on Drug Abuse, 1993), pp. 15-30.",
76,GAO/GGD-97-42,Table II.3: d,49,Article,,,WOS:A1994MY61500001,8192128,,"Elizabeth Wells et al., “Outpatient Treatment for Cocaine Abuse: A Controlled Comparison of Relapse Prevention and Twelve-Step Approaches,” American Journal of Drug and Alcohol Abuse, 20:1 (1994), 1-17.",
77,GAO/GGD-97-42,Table II.3: e,112,Article,,,WOS:A1991GD55200016,1883001,,"Stephen Higgins et al., “A Behavioral Approach to Achieving Initial Cocaine Abstinence,” American Journal of Psychiatry, 148:9 (1991), 1218-24.",
78,GAO/GGD-97-42,Table II.3: f,111,Article,,,WOS:A1993LA32300014,8480823,,"Stephen Higgins et al., “Achieving Cocaine Abstinence With a Behavioral Approach,” American Journal of Psychiatry, 150:5 (1993), 763-69.",
79,GAO/GGD-97-42,Table II.3: g.1,67,Monograph ,,,,,Not found in WoS,"K. Silverman et al., “Differential Reinforcement of Sustained Cocaine Abstinence in Intravenous Polydrug Abusers,” in L. S. Harris (ed.), Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph 153 (Rockville, Md.: National Institute on Drug Abuse Research, 1995), p. 212,",
80,GAO/GGD-97-42,Table II.3: g.2,68,Monograph ,,,,,Not found in WoS,"K. Silverman et al., “Voucher-Based Reinforcement of Cocaine Abstinence: Effects of Reinforcement Schedule,” in L. S. Harris (ed.), Problems of Drug Dependence 1995: Proceedings of the 57th Annual Scientific Meeting, The College on Problems of Drug Dependence. National Institute on Drug Abuse Research Monograph, in press.",
81,GAO/GGD-97-42,Table II.3: g.3,100,?,,,,,,"NIDA Notes, 10:5 (September-October 1995), 10 and 14.",
82,GAO/GGD-97-42,Table II.3: h,115,Article,,,WOS:A1994QM23100003,7734464,,"Steven Shoptaw et al., “The Matrix Model of Outpatient Stimulant Abuse Treatment: Evidence of Efficacy,” Journal of Addictive Diseases, 13:4 (1994), 129-41.",
83,GAO/GGD-97-42,Table II.3: i,106,Monograph,,,,8289906,,"Richard Rawson et al., “Neurobehavioral Treatment for Cocaine Dependency: A Preliminary Evaluation,” Cocaine Treatment: Research and Clinical Perspectives. National Institute on Drug Abuse Research Monograph #135 (Rockville, Md.: National Institute on Drug Abuse, 1993), pp. 92-115.",
84,GAO/GGD-97-42,Table II.3: j.1,7,Article,,,WOS:A1995RH46500004,7562262,,"Andrew Rosenblum et al., “Treatment Intensity and Reduction in Drug Use for Cocaine-Dependent Methadone Patients: A Dose Response Relationship.”",
85,GAO/GGD-97-42,Table II.3: j.2,8,Conference Proceeding,,,,,Not found in Wos,"Andrew Rosenblum et al., “Treatment Intensity and Reduction in Drug Use for Cocaine-Dependent Methadone Patients: A Dose Response Relationship.” A prior version of this paper was presented at the American Society of Addiction Medicine Annual Conference, New York, N.Y., April 1994.",
86,GAO/GGD-97-42,Table II.3: k,114,Article,,,WOS:A1994QM23100004,7734465,,"Stephen Magura et al., “Neurobehavioral Treatment for Cocaine-Using Methadone Patients: A Preliminary Report,” Journal of Addictive Diseases, 13:4 (1994), 143-60.",
111,GAO/GGD/HEHS-98-140,1,1,Report,,,,,,"“Summary of State Laws and Regulations Relating to Distilled Spirits,” 29th edition, 1996.",
112,GAO/GGD/HEHS-98-140,2,,Comment,,,,,,OMIT,
113,GAO/GGD/HEHS-98-140,3,,Comment,,,,,,OMIT,
114,GAO/GGD/HEHS-98-140,4,,Comment,,,,,,OMIT,
115,GAO/GGD/HEHS-98-140,5,,Comment,,,,,,OMIT,
116,GAO/GGD/HEHS-98-140,6,99,Report,,,,,Not found in WoS,"NIAAA, “Prevention of Alcohol Problems,” Chapter 9 of Alcohol and Health: Ninth Special Report to the U.S. Congress, U.S. Department of Health and Human Services, June 1997, pp. 301-327.",
117,GAO/GGD/HEHS-98-140,7,,Comment,,,,,,OMIT,
118,GAO/GGD/HEHS-98-140,8,,Comment,,,,,,OMIT,
119,GAO/GGD/HEHS-98-140,9,,Comment,,,,,,OMIT,
120,GAO/GGD/HEHS-98-140,10,,Comment,,,,,,OMIT,
121,GAO/GGD/HEHS-98-140,11,,Comment,,,,,,OMIT,
122,GAO/GGD/HEHS-98-140,12,,Comment,,,,,,OMIT,
123,GAO/GGD/HEHS-98-140,13,,Comment,,,,,,OMIT,
124,GAO/GGD/HEHS-98-140,14,,Comment,,,,,,OMIT,
127,GAO/GGD/HEHS-98-140,16,,Comment,,,,,,OMIT,
128,GAO/GGD/HEHS-98-140,17,,Comment,,,,,,OMIT,
129,GAO/GGD/HEHS-98-140,18,,Comment,,,,,,OMIT,
130,GAO/GGD/HEHS-98-140,19,,Comment,,,,,,OMIT,
131,GAO/GGD/HEHS-98-140,20,,Comment,,,,,,OMIT,
132,GAO/GGD/HEHS-98-140,21,,Comment,,,,,,OMIT,
133,GAO/GGD/HEHS-98-140,22,,Comment,,,,,,OMIT,
134,GAO/GGD/HEHS-98-140,23,56,Article,,,WOS:A1995QR05900029,,,"Gilbert J. Botvin et al., “Long-term Follow-up Results of a Randomized Drug Abuse Prevention Trial in a White Middle-Class Population,” Journal of the American Medical Association, 273:14 (1995), pp. 1106-12.",
135,GAO/GGD/HEHS-98-140,24,99,Report,,,,,Not found in WoS,"NIAAA, “Prevention of Alcohol Problems,” Chapter 9 of Alcohol and Health: Ninth Special Report to the U.S. Congress, U.S. Department of Health and Human Services, pp. 305-306, 1997.",
138,GAO/GGD/HEHS-98-140,25,3,Litigation,,,,,,"44 Liquormart v. Rhode Island, 517 U.S. 484 (1996)",
139,GAO/GGD/HEHS-98-140,26,,Comment,,,,,,OMIT,
140,GAO/GGD/HEHS-98-140,27,36,Legislation,,,,,,District’s Fiscal Year 1998 Appropriations Act,
141,GAO/GGD/HEHS-98-140,28,105,Article,,,,,Not found in WoS,"Ralph Hingson, “Prevention of Alcohol-Impaired Driving,” Alcohol Health and Research World, Vol. 17, No. 1(1993), pp. 28-34.",
142,GAO/GGD/HEHS-98-140,29,65,Legislation,,,,,,Intermodal Surface Transportation Efficiency Act of 1998.,
143,GAO/GGD/HEHS-98-140,30,5,Journal Issue,,,,,Not found,"Addiction: A Community Prevention Trial to Reduce Alcohol-Involved Trauma, Vol. 92, Supplement 2, June 1997.",
144,GAO/GGD/HEHS-98-140,31,72,Conference proceeding,,,,,Not found in WoS,"Kelli A. Komro et al., “Project Northland - Phase II: Research and Evaluation Design of a Community-Wide Program to Reduce Adolescent Alcohol Use.” Proceedings published from a Kettil Bruun Society Thematic Meeting, Fourth Symposium on Community Action Research and the Prevention of Alcohol and Other Drug Problems, February 8-13, 1998, New Zealand, forthcoming.",
125,GAO/GGD/HEHS-98-140,15a,28,Report,"Working Paper No. 1852, 1986",10.1086/467152,WOS:A1988N389200006,,,"Coate, Douglas and Michael Grossman, “Effects of Alcoholic Beverage Prices and Legal Drinking Ages on Youth Alcohol Use,” Cambridge, MA: National Bureau of Economic Research, Working Paper No. 1852, 1986;",
126,GAO/GGD/HEHS-98-140,15b,12,Article,,,WOS:A1985AJL5500010,4010301,,"Berger, Dale and John Snortum, “Alcoholic Beverage Preferences of Drinking-Driving Violators,” Journal of Studies on Alcohol, 46(3), 1985, pp. 232-239.",
192,GAO/GGD/HEHS-98-140,Appendix I.1,,Comment,,,,,,OMIT,
193,GAO/GGD/HEHS-98-140,Appendix I.2,,Comment,,,,,,OMIT,
194,GAO/GGD/HEHS-98-140,Appendix I.3,,Comment,,,,,,OMIT,
167,GAO/GGD/HEHS-98-140,Appendix II.a,50,Report,,,,,,"Federation of Tax Administrators, “State Alcoholic Beverage Excise Tax Rates as of January 1, 1998”",
145,GAO/GGD/HEHS-98-140,Appendix II.b,2,Report,,,,,,"“Tax Briefs” prepared by the Distilled Spirits Council of the United States, December 1996.",
170,GAO/GGD/HEHS-98-140,Appendix III.10a,60,Report,,,,,Not found in WoS,"Grossman, Michael, “The Economic Analysis of Addictive Behavior,” in Hilton, Michael and Gregory Bloss, eds. Economics and the Prevention of Alcohol-Related Problems, NIAAA Research Monograph No. 25, National Institutes of Health Pub. No. 93-3513, U.S. Department of Health and Human Services, 1993, pp. 91, 114;",
160,GAO/GGD/HEHS-98-140,Appendix III.10b,17,Article,,,,,Not Found in WOS,"Chaloupka, Frank, “The Effects of Price on Alcohol Consumption,” forthcoming, 1997, p. 5",
191,GAO/GGD/HEHS-98-140,Appendix III.11,97,Report,,,,,Not found in WoS,"NIAAA, “Economic Aspects of Alcohol Use and Alcohol-Related Problems,” Chapter 8 of Alcohol and Health: Ninth Special Report to the U.S. Congress, U.S. Dept. of Health and Human Services, June 1997.",
173,GAO/GGD/HEHS-98-140,Appendix III.12,66,Article,,,WOS:A1990CH49600013,,,"Johnson et al., “Alternative Approaches to the Measurement of Consumption and Price of Alcoholic Beverages, Canada, 1957-1983,” Journal of Studies on Alcohol, 51(1), 1990, p. 82.",
196,GAO/GGD/HEHS-98-140,Appendix III.13,,Comment,,,,,,OMIT,
197,GAO/GGD/HEHS-98-140,Appendix III.14,,Comment,,,,,,OMIT,
184,GAO/GGD/HEHS-98-140,Appendix III.15,84,Article,,,WOS:A1995RE40500001,10154654,,"Manning, Willard et al., “The Demand For Alcohol: The Differential Response to Price,” Journal of Health Economics, 14(2), 1995, pp. 137-139.",
177,GAO/GGD/HEHS-98-140,Appendix III.16,73,Conference Proceeding,,,WOS:A1993MT21500008,,,"Kenkel, Donald, “Drinking, Driving, and Deterrence: The Effectiveness and Social Costs of Alternative Policies,” Journal of Law and Economics, XXXVI, October 1993, pp. 889-890.",
178,GAO/GGD/HEHS-98-140,Appendix III.17,77,Article,,,WOS:A1996UD26200008,,,"Kenkel, Donald, “New Estimates of the Optimal Tax on Alcohol, Economic Inquiry, XXXIV, April 1996, p. 307.",
157,GAO/GGD/HEHS-98-140,Appendix III.18a,14,Article,,,WOS:A1996VP78500010,,,"Chaloupka, Frank and Henry Wechsler, “Binge Drinking in College: The Impact of Price, Availability, and Alcohol Control Policies,” Contemporary Economic Policy, 14(4), October 1996, pp. 112-124;",
179,GAO/GGD/HEHS-98-140,Appendix III.18b,78,Personal Communication,,,,,,"Kenkel, Donald, personal communication, 1998, p. 4.",
163,GAO/GGD/HEHS-98-140,Appendix III.19a,28,Article,,,WOS:A1988N389200006,,,"Coate, Douglas and Michael Grossman, “Effects of Alcoholic Beverage Prices and Legal Drinking Ages on Youth Alcohol Use,” Journal of Law and Economics, XXXI, April 1988, p. 152;",
147,GAO/GGD/HEHS-98-140,Appendix III.19b,12,Article,,,WOS:A1985AJL5500010,4010301,,"Berger, Dale and John Snortum, “Alcoholic Beverage Preferences of Drinking-Driving Violators,” Journal of Studies on Alcohol, 46(3), 1985, p. 232;",
168,GAO/GGD/HEHS-98-140,Appendix III.19c,58,Article,,,WOS:A1987J512900004,,,"Grossman et al., 1998, p. 40; Saffer, Henry and Michael Grossman, “Beer Taxes, the Legal Drinking Age, and Youth Motor Vehicle Fatalities,” The Journal of Legal Studies, XVI, June 1987, pp. 353-354;",
148,GAO/GGD/HEHS-98-140,Appendix III.19d,14,Article,,,WOS:A1996VP78500010,,,"Chaloupka and Wechsler, 1996, p. 116.",
146,GAO/GGD/HEHS-98-140,Appendix III.20,12,Article,,,WOS:A1985AJL5500010,4010301,,"Berger and Snortum, pp. 232-239.",
174,GAO/GGD/HEHS-98-140,Appendix III.21a,73,Conference Proceeding,,,WOS:A1993MT21500008,,,"Kenkel 1993, p. 895; ",
,GAO/GGD/HEHS-98-140,Appendix III.21ab,71,Monograph ,,,,,Not found in WoS,"Leung and Phelps, p. 23;",
161,GAO/GGD/HEHS-98-140,Appendix III.21b,25,Personal Communication,,,,,,"Chaloupka, Frank, personal communication, 1998, p. 1.",
200,GAO/GGD/HEHS-98-140,Appendix III.22,102,Article,,,WOS:A1988P829400001,10288441,,"Phelps, Charles, “Death and Taxes: An Opportunity for Substitution,” Journal of Health Economics, 7, 1988, p. 10.",
169,GAO/GGD/HEHS-98-140,Appendix III.23,59,Article,,,WOS:000071347800005,,,"Grossman, Michael et al., “An Empirical Analysis of Alcohol Addiction: Results from the Monitoring the Future Panels, Economic Inquiry, XXXVI, January 1998, pp. 40, 45.",
180,GAO/GGD/HEHS-98-140,Appendix III.24,79,Report,,,,,Similar conference proceeding found in WOS with different date. WOS:A1993MD39100007,"Laixuthai, Adit and Frank Chaloupka, Youth Alcohol Use and Public Policy, Cambridge, MA: National Bureau of Economic Research, Working Paper No. 4278, February 1993, pp. 1, 14-16.",
164,GAO/GGD/HEHS-98-140,Appendix III.25a,28,Article,,,WOS:A1988N389200006,,,"Coate, Douglas and Michael Grossman, “Effects of Alcoholic Beverage Prices and Legal Drinking Ages on Youth Alcohol Use,” Journal of Law and Economics, XXXI, April 1988, pp. 145, 151, 164.;",
171,GAO/GGD/HEHS-98-140,Appendix III.25b,60,Report,,,,,Not found in WoS,"Grossman, Michael, “The Economic Analysis of Addictive Behavior,” in Hilton, Michael and Gregory Bloss, eds. Economics and the Prevention of Alcohol-Related Problems, NIAAA Research Monograph No. 25, NIH Pub. No. 93-3513, U.S. Department of Health and Human Services, 1993, pp. 109, 111, 114-115",
182,GAO/GGD/HEHS-98-140,Appendix III.25c1,71,Monograph ,,,,,Not found in WoS,"Leung and Phelps, pp. 19-20; ",
,GAO/GGD/HEHS-98-140,Appendix III.25c2,97,Report,,,,,Not found in WoS,"NIAAA, p. 282; ",
,GAO/GGD/HEHS-98-140,Appendix III.25c3,102,Article,,,WOS:A1988P829400001,10288441,,"Phelps, pp. 9-10.",
162,GAO/GGD/HEHS-98-140,Appendix III.26,28,Article,,,WOS:A1988N389200006,,,"Coate and Grossman, 1988, pp. 145, 151, 164",
181,GAO/GGD/HEHS-98-140,Appendix III.27,71,Monograph ,,,,,Not found in WoS,"Leung and Phelps, pp. 18-20",
149,GAO/GGD/HEHS-98-140,Appendix III.28,14,Article,,,WOS:A1996VP78500010,,,"Chaloupka and Wechsler, 1996, p. 120.",
151,GAO/GGD/HEHS-98-140,Appendix III.29,16,Article,,,WOS:A1993KX47000007,,,"Chaloupka et al., “Alcohol Control Policies and Motor-Vehicle Fatalities,” Journal of Legal Studies, XXII, January 1993, pp. 165, 181.",
185,GAO/GGD/HEHS-98-140,Appendix III.30a,84,Article,,,WOS:A1995RE40500001,10154654,,"Manning, Willard et al., p. 139; ",
,GAO/GGD/HEHS-98-140,Appendix III.30b,73,Article,,,WOS:A1993MT21500008,,,"Kenkel, pp. 889-890",
158,GAO/GGD/HEHS-98-140,Appendix III.31,23,Article,,,,,Not Found in WOS,"Chaloupka, Frank et al., in Recent Developments in Alcoholism, forthcoming, pp. 21-22.",
159,GAO/GGD/HEHS-98-140,Appendix III.32,24,Article,,,,,Not Found in WOS,"Chaloupka, Frank et al., in Recent Developments in Alcoholism, forthcoming, pp. 9-10, 15-21.",
199,GAO/GGD/HEHS-98-140,Appendix III.33,102,Article,,,WOS:A1988P829400001,10288441,,"Phelps, 1988; ",
,GAO/GGD/HEHS-98-140,Appendix III.33a,73,Conference Proceeding,,,WOS:A1993MT21500008,,,"Kenkel, 1993.",
188,GAO/GGD/HEHS-98-140,Appendix III.34,93,Article,,,WOS:A1994NZ59100002,,,"Mullahy, John and Jody Sindelar, “Do Drinkers Know When to Say When? An Empirical Analysis of Drunk Driving,” Economic Inquiry, XXXII, July 1994, pp. 383-394.",
198,GAO/GGD/HEHS-98-140,Appendix III.35,,Comment,,,,,,OMIT,
202,GAO/GGD/HEHS-98-140,Appendix III.36,58,Article,,,WOS:A1987J512900004,,,"Saffer, Henry and Michael Grossman, “Beer Taxes, the Legal Drinking Age, and Youth Motor Vehicle Fatalities,” Journal of Legal Studies, June 1987, pp. 351-353, 373-374.",
154,GAO/GGD/HEHS-98-140,Appendix III.37,16,Article,,,WOS:A1993KX47000007,,,"Chaloupka et al., 1993. Drinkers who prefer beer are more likely to drive while intoxicated than those who prefer wine or liquor.",
186,GAO/GGD/HEHS-98-140,Appendix III.38,91,Article,,,WOS:A1993LP31200004,,,"Mullahy and Sindelar, pp. 383-394.",
201,GAO/GGD/HEHS-98-140,Appendix III.39,107,Article,,,WOS:A1996VZ07100003,10164038,,"Ruhm, C.J., “Alcohol Policies and Highway Vehicle Fatalities,” Journal of Health Economics, 15(4), 1996, pp. 435-454.",
204,GAO/GGD/HEHS-98-140,Appendix III.40,110,Article,,,WOS:A1995RT26300003,,,"Sloan, F. et al., “Effects of Tort Liability and Insurance on Heavy Drinking and Drinking and Driving,” Journal of Law and Economics, 38(1), 1995, pp. 49-78",
150,GAO/GGD/HEHS-98-140,Appendix III.41a,15,Article,,,,,Not Found in WOS,"Chaloupka et al., “Alcohol Addiction: An Econometric Analysis,” presented at the annual meeting of the Allied Social Science Associations, Anaheim, CA, December 1992; ",
150.5,GAO/GGD/HEHS-98-140,Appendix III.41b,30,Article,,,WOS:A1982PX95100007,,,"Cook, Philip and George Tauchen, “The Effect of Liquor Taxes on Heavy Drinking,” Bell Journal of Economics, 12, 1982, p. 379.",
203,GAO/GGD/HEHS-98-140,Appendix III.42,109,Article,,,WOS:A1994NT49400008,7934053,,"Sloan, F. et al., “Effects of Prices, Civil and Criminal Sanctions, and Law Enforcement on Alcohol-Related Mortality,” Journal of Studies on Alcohol, 55, 1994, pp. 454-465.",
156,GAO/GGD/HEHS-98-140,Appendix III.43,21,Article,,,,,Not found in Wos,"Chaloupka, Frank and Henry Saffer, “Alcohol, Illegal Drugs, Public Policy and Crime,” presented at the annual meeting of the Western Economic Association, San Francisco, CA, July 1992; Cook, Philip and Michael Moore, “Economic Perspectives on Reducing Alcohol-Related Violence,” in Martin, S. E. ed., Alcohol and Interpersonal Violence: Fostering Multidisciplinary Perspectives, Washington, DC: U. S. GPO, 1993, p. 193.",
165,GAO/GGD/HEHS-98-140,Appendix III.44,33,Article,,,WOS:A1993MU68200003,10131754,,"Cook, Philip and Michael Moore, “Drinking and Schooling,” Journal of Health Economics, 12, 1993, p. 411; Yamada, T. et al., “The Impact of Alcohol Consumption and Marijuana Use on High School Graduation,” Health Economics, 5, 1996, p. 77.",
166,GAO/GGD/HEHS-98-140,Appendix III.45,34,Monograph,,,,,Not found in WoS,"Cook, Philip and Michael Moore, “Taxation of Alcoholic Beverages,” in Hilton, Michael and Gregory Bloss, eds., Economics and the Prevention of Alcohol-Related Problems, NIAAA Research Monograph No. 25, NIH Pub. No. 93-3513, U. S. Department of Health and Human Services, 1993, pp. 33, 50.",
175,GAO/GGD/HEHS-98-140,Appendix III.46a,74,Article,,,WOS:A1994NX79100003,,,"Kenkel, Don and D. Ribar, “Alcohol Consumption and Young Adults’ Socioeconomic Status,” Brookings Papers on Economic Activity, 1, 1994, p. 119;",
187,GAO/GGD/HEHS-98-140,Appendix III.46b,92,Article,,,WOS:A1993LP31200004,,,"Mullahy, J. and Jody Sindelar, “Alcoholism, Work, and Income,” Journal of Labor Economics, 11(3), 1993, p. 494;",
172,GAO/GGD/HEHS-98-140,Appendix III.46c,61,Report,,,,,Not found in WoS,"Harwood, H. J. et al., “Economic Costs to Society of Alcohol, Drug Abuse and Mental Illness,” Research Triangle Institute, 1984.",
153,GAO/GGD/HEHS-98-140,Appendix III.4a,18,Article,,,,,Not found in wos,"Chaloupka et al., “The Effects of Price on the Consequences of Alcohol Use and Abuse,” in M. Galanter, ed. Recent Developments in Alcoholism, vol. 14: The Consequences of Alcoholism: Medical, Neuropsychiatric, Economic, Cross-Cultural, New York: Plenum Publishing Corp. forthcoming;",
152,GAO/GGD/HEHS-98-140,Appendix III.4b,17,Article,,,,,Not Found in WOS,"Chaloupka et al., “The Effects of Price on Alcohol Consumption,” Alcohol Health and Research World, forthcoming.",
155,GAO/GGD/HEHS-98-140,Appendix III.5,20,Article,,,,,Not found in WOS,"Chaloupka et al., Alcohol Health and Research World, forthcoming",
176,GAO/GGD/HEHS-98-140,Appendix III.6,75,Article,,,WOS:A1996WN68600005,,,"Kenkel, Donald and Willard Manning, “Perspectives on Alcohol Taxation,” Alcohol Health and Research World, 20(4), 1996, pp. 233-234.",
183,GAO/GGD/HEHS-98-140,Appendix III.7,71,Monograph ,,,,,Not found in WoS,"Leung, Siu Fai and Charles Phelps, “My Kingdom for a Drink. . . ? A Review of Estimates of the Price Sensitivity of Demand for Alcoholic Beverages,” in Hilton, Michael and Gregory Bloss, eds. Economics and the Prevention of Alcohol-Related Problems, National Institute on Alcohol Abuse and Alcoholism Research Monograph No. 25, NIH Pub. No. 93-3513, U.S. Department of Health and Human Services, 1993.",
195,GAO/GGD/HEHS-98-140,Appendix III.8,,Comment,,,,,,OMIT,
190,GAO/GGD/HEHS-98-140,Appendix III.9,97,Report,,,,,Not found in WoS,"National Institute on Alcohol Abuse and Alcoholism, “Economic Aspects of Alcohol Use and Alcohol-Related Problems,” Chapter 8 of Alcohol and Health: Ninth Special Report to the U.S. Congress, U.S. Dept. of Health and Human Services, June 1997, pp. 282, 284-285.",
189,GAO/GGD/HEHS-98-140,Appendix IV,94,Report,,,,,,"National Conference of State Legislatures, Earmarking State Taxes (April 1995).",
205,GAO/GGD/HEHS-98-140,Appendix V,123,Legislation,,,,,,"The statutes of the District of Columbia, Maryland, and Virginia.",
136,GAO/GGD/HEHS-98-140,Table 7.a,104,Legislation,,,,,,Public Law 100-690,
137,GAO/GGD/HEHS-98-140,Table 7.b,,Comment,,,,,,OMIT,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,
,,,,,,,,,,,